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CHAPTER I 
 
INTRODUCTION 
 
Helicobacter pylori 
As early as 1938, spiral shaped bacteria were reported to colonize the human 
gastric mucus layer (1, 2).  Since the organisms could not be grown in culture, however, 
and since the stomach was considered an inhospitable environment, the results were 
largely ignored.  In 1982, Barry J. Marshall and J. Robin Warren isolated the bacteria 
and made the remarkable and unexpected discovery that inflammation and ulceration in 
the stomach as well as ulceration of the duodenum can be the result of an infection 
caused by the gram-negative bacterium Helicobacter pylori (3, 4).   When Warren and 
Marshall announced their findings, it was a long-standing belief in medical practice that 
stress and lifestyle were the major causes of peptic ulcer disease.  In response to critics, 
Marshall underwent gastric biopsy to verify that he didn't carry the bacterium, then 
deliberately infected himself by ingesting a liquid culture to show that H. pylori, in fact, 
caused acute gastric illness (5).  Biopsy confirmed an infection that could then be treated 
with antibiotics.  It soon became clear that H. pylori causes more than 90% of duodenal 
ulcers and up to 80% of gastric ulcers (6-12).  Warren and Marshall were awarded the 
Nobel Prize in Medicine in 2005 for “their discovery of Helicobacter pylori and its role in 
gastritis and peptic ulcer disease.”  
More than half of the world’s human population is persistently colonized with H. 
pylori  (13).  In developing countries, 70 to 90% of the population carries H. pylori, and in 
developed countries the prevalence of infection is lower, ranging from 25 to 50% (14).  
H.  pylori penetrates and colonizes the human gastric mucosa, an inherently inhospitable 
acidic environment.  H. pylori is highly adapted to this ecologic niche and may persist for 
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decades, despite the host immune and inflammatory responses.   In the absence of H. 
pylori, the gastric mucosa contains very few immune or inflammatory cells, however, all 
H. pylori-infected individuals develop chronic gastric inflammation (15, 16).  While often 
asymptomatic, the chronic inflammation associated with infection makes H. pylori a 
significant risk factor for the development of several gastroduodenal diseases.  These 
include gastric adenocarcinoma, gastric and duodenal ulceration, gastric MALT 
lymphoma, and gastric non-Hodgkins lymphoma (4, 11, 12, 17-25). The biological 
determinants of clinical outcome are poorly understood, in part because of genetic 
heterogeneity among H. pylori isolates, but also due to heterogeneity within the human 
hosts and variable environmental factors.   
The complete genome sequences of multiple H. pylori strains have been 
determined (10, 26-30).  These H. pylori genomes consist of circular chromosomes 
about 1.6 to 1.73 Mb in size (31).  This relatively small size probably reflects a limited 
metabolic repertoire and biosynthetic capacity and is consistent with the specialization of 
H. pylori growth in its restricted niche (32).  H. pylori strains from unrelated humans 
exhibit a high level of genetic diversity, and the rate of recombination in H. pylori is 
reported to be among the highest in the Eubacteria (17, 33).   For example, a single host 
can carry multiple closely related H. pylori strains that are derived from one parental 
strain by a series of mutations, chromosomal rearrangements, and recombination events 
(34).  The population structure of H. pylori is panmictic (17, 35-37).  A panmictic 
structure is caused by recombination and horizontal genetic exchange, where foreign 
DNA, from intraspecies recombination, is integrated and disrupts clonal structure, 
resulting in newly introduced DNA that does not share the same evolutionary history as 
the other genes within the genome.  Furthermore, H. pylori exhibits sequence diversity in 
multiple genes, including those that encode urease (38) and accessory proteins (39), 
 3  
flagellin (40), vacuolating cytotoxin (VacA) (41) and cytotoxin-associated gene (CagA) 
(42-44).   
 
H. pylori virulence factors  
In gastric biopsy specimens, H. pylori are 2.5 to 5.0 µm long, 0.5 to 1.0 µm wide, 
and have four to six unipolar sheathed flagella (45).  The lumenal pH of the human 
stomach is < 2, but within the gastric mucus there is a pH gradient that ranges from pH 2 
to pH 7.0 (46).  H. pylori entry into the gastric mucus layer is presumably an important 
feature that permits escape from the extremely low pH environment of the stomach.  
Flagella are essential for moving through the stomach lumen and penetrating the mucus 
layer, which then allows for colonization (47).    
Secreted bacterial products are thought to play an important role in the 
pathogenesis of H. pylori-associated diseases.   Secreted proteins are of special 
interest, because they come in direct contact with host tissues and may mediate 
important host - pathogen interactions. Urease is one important colonization factor that 
neutralizes the pH environment for the organism by catalyzing the hydrolysis of urea to 
ammonium and CO2 (48).  The enzyme is produced in abundance by all fresh clinical H. 
pylori isolates but not required for H. pylori growth in vitro (49-52).   
A second important H. pylori virulence factor is the secreted CagA effector 
protein.  The cagA gene is localized within a 40-kb chromosomal region known as the 
cag pathogenicity island (cag PAI) (53).  H. pylori strains expressing CagA are 
associated with a significantly increased risk for development of ulcer disease or gastric 
cancer compared to strains that lack the cagA gene (54).  Upon entry into cells, CagA 
undergoes phosphorylation by host cell kinases and induces numerous alterations in 
cellular signaling, leading to the designation of CagA as a “bacterial oncoprotein” (55-
59).   
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Another important virulence factor in the pathogenesis of H. pylori infection is a 
secreted protein known as vacuolating cytotoxin (VacA).  Soon after the discovery of H. 
pylori it was reported that a protein in H. pylori broth culture filtrates could cause the 
formation of large intracellular vacuoles in the cytoplasm of mammalian cells (60-62).  A 
chromosomal gene known as vacA encodes the H. pylori protein responsible for this 
effect, vacuolating cytotoxin or VacA.  The amino acid sequence of VacA does not have 
similarity to any other known bacterial or eukaryotic protein.  Mature VacA toxin 
molecules are secreted as soluble proteins into the extracellular space, but can also 
remain localized on the surface of H. pylori.   
 
Role of VacA in disease  
All strains of H. pylori that have been isolated from humans (H. pylori is isolated 
from nonhuman primates as well) contain the vacA gene, which suggests that production 
of VacA is important for colonization or persistence of H. pylori in the human stomach.  
While all strains of H. pylori that have been isolated contain the vacA gene, not all VacA 
proteins are cytotoxic in vitro, which is due to allelic diversity in two regions:  the signal 
sequence region, or s region, and the midregion, referred to as the m region (Figure 1) 
(63, 64).  VacA molecules of the s2 type are inactive in assays for vacuolating 
cytotoxicity, type s1/m1 forms produce extensive vacuolation of many different cell types 
and type s1/m2 forms produce detectable vacuolation in a more limited range of cell 
types (63, 65-69).  Strains of H. pylori that contain certain allelic forms of vacA are 
associated with an increased risk of symptomatic gastroduodenal disease compared 
with strains containing other allelic forms of vacA (63, 68-71).  In particular, H. pylori 
strains that contain vacA alleles of the s1 type are associated with an increased risk for 
development of peptic ulcer disease and gastric cancer compared with strains containing 
vacA alleles of the s2 type (63, 64, 69, 70).  These data can be correlated with the failure 
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of type s2 forms of VacA to cause detectable vacuolation in vitro.  In addition, strains 
containing type m1 vacA alleles are associated with an increased risk for development of 
gastric epithelial injury and gastric cancer compared with strains containing vacA alleles 
of the m2 type (70, 72).   
To experimentally investigate whether the production of VacA contributes to 
gastric disease, large quantities of the VacA protein have been administered directly into 
the stomach of mice (73).  This procedure causes gastric mucosal injury and gastric 
inflammation.  Another approach has been to infect animals with isogenic wildtype and 
vacA-null mutant strains of H. pylori and compare the disease pathologies.  Gastric 
histology of infected gnotobiotic piglets suggests that VacA does not contribute to 
disease (74), whereas it does contribute to the pathogenesis of gastric ulceration in 
gerbils (75).  The lack of a good animal model has made understanding the role of VacA 
in pathogenesis difficult to study.   
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Figure 1.  vacA gene structure.   There is a high level of diversity among vacA alleles 
from different H. pylori strains.  Allelic diversity is particularly striking near the 5’ terminus 
of vacA (the s-region) and in the mid-region of the gene (m-region).  Two main families 
of s-region sequences (s1 and s2) and two main families of m-region sequences (m1 
and m2) have been described.  Adapted from Cover et al.  2005 (57). 
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VacA effects on cells  
In order to understand how VacA contributes to H. pylori colonization of the 
stomach and the development of gastroduodenal disease, the effects of VacA on human 
cells have been investigated in vitro.  VacA can infect many different cell types, including 
gastric epithelial cells and several types of immune cells, resulting in alteration of cellular 
functions.  Many of these activities are dependent on the formation of anion-selective 
channels in the membranes of host cells (61, 76-80).  VacA is named for is capacity to 
induce extensive vacuolation in the cytoplasm of mammalian cells (55).  These vacuoles 
arise from anion-selective channels in endosomal membranes followed by swelling of 
endosomal compartments (61, 78, 79, 81).  To form vacuoles in response to purified 
VacA, a weak base such as ammonium chloride is needed (56, 82, 83).  In addition to 
vacuolation, other channel dependent effects include depolarization of epithelial cells 
(84), transfer of ions and nutrients (85, 86), inhibition of T cell proliferation (87-89), and 
the release of cytochrome c from mitochondria resulting in the induction of epithelial cell 
apoptosis (90).  Furthermore, the toxin is able to perturb a number of signaling 
pathways, independent of its channel-forming activity.  For example, VacA is known to 
activate the G-protein coupled receptor kinase interacting protein (Git)1 and p38 (91, 
92).   
 
VacA primary structure and secretion  
Gram-negative bacteria have evolved six secretion pathways (type I-VI) for the 
transport of proteins across the cell membrane (93, 94).  They range from relatively 
simple structures such as type I secretion systems, composed of three subunits that only 
secrete one substrate protein, to complex machines such as type III and IV secretion 
systems, composed of more than 20 subunits that can translocate large sets of effector 
proteins into eukaryotic target cells.    
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The vacA gene encodes a 140-kDa protoxin, which undergoes N- and C-terminal 
cleavage during the secretion process to yield a mature 88-kDa toxin, p88 (41, 73, 95).  
Secretion is thought to occur through a Type Va or autotransporter pathway in which an 
N-terminal signal sequence directs the protein to the periplasm via the Sec pathway and 
a C-terminal β-barrel domain facilitates transport of the  ‘passenger’ domain across the 
outer membrane (Figure 2) (96).  Outer membrane secretion occurs in an energy 
independent mechanism.  Following secretion, the passenger domain is cleaved from 
the autotransporter domain either by its own protease activity (currently none are known 
for VacA) or by another protease.    
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Figure 2.  VacA structure and model of VacA translocation across the outer 
membrane.  (A) The vacA gene encodes a 140-kDa protoxin.  The passenger domain is 
the mature 88-kDa VacA toxin, which contains two domains, designated p33 and p55.  
The midregion sequence that defines type m1 and m2 forms of VacA is located within 
p55.  (B) The signal sequence (purple) directs the protein to the periplasm through the 
Sec machinery.  Following translocation into the periplasm and cleavage of the N-
terminal signal peptide, the C-termianl β-barrel domain (blue) folds into the outer 
membrane.  The passenger domain (black) is translocated across the outer membrane 
in an unfolded or partially folded state.  Following export, or possibly concurrent with 
translocation onto the cell surface, folding of the passenger domain occurs.  Cleavage of 
the VacA passenger domain is mediated by an unknown mechanism.  Orange box in the 
inner membrane represents the Sec machinery.  Blue box in the outer membrane 
represents the β-barrel domain.    
 
 
 
Passenger Domain 
β-barrel 
Sec Sec 
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VacA receptor binding  
For most bacterial toxins, cellular intoxication is initiated by binding of the toxin to 
a receptor on the plasma membrane.  Several bacterial toxins, such as diphtheria toxin 
(97), bind a single receptor on the surface of the host cell.  In contrast, VacA has been 
reported to bind to multiple cell-surface components.  These include two receptor-linked 
protein tyrosine phosphatase proteins, RPTP-α and RPTP-β (91, 98, 99).  These 
proteins do not share sequence homology in their extracellular domains but could 
contain a common receptor-binding site if a common sugar moiety is involved.  RPTP-β 
has been shown to mediate VacA induced gastric damage in a mouse intoxication model 
(91).  Mice deficient in RPTP-β do not show mucosal damage by VacA, although gastric 
epithelial cell vacuolation still occurs.  Instead, the RPTP-β mediated effect on Git1 
signaling is proposed as the mechanism of VacA-induced gastric damage (91).  The 
RPTP-α and RPTP-β receptors are present in both epithelial cells and T cells but it is 
unclear which cellular events they mediate and if they discriminate between m1 and m2 
forms of VacA.  Additionally, the β2 (CD18) integrin subunit has been identified as a 
leukocyte-specific receptor for m1-VacA on human T cells (100).  VacA efficiently enters 
activated, primary human T lymphocytes by binding to the CD18 integrin subunit and 
exploiting the recycling of lymphocyte function-associated antigen (LFA)-1. Furthermore, 
various lipids have been shown to interact with VacA, but the importance of VacA-lipid 
interactions for toxin function remains to be established (61, 101-103).   Most recently, 
sphingomyelin (SM), a key structural component of the cell membrane, has been shown 
to modulate the sensitivity of epithelial cells to VacA (104).  It still remains unclear how 
SM-dependent association of VacA promotes toxin uptake. 
Studies of the VacA interaction with the cell surface have been complicated by 
the potential for this toxin to interact with multiple cell-surface components and for the 
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relevant cell-surface receptors to vary among different cell types.   In addition, type m1 
and m2 VacA have differences in cell type specificity and might preferentially bind to 
different cell-surface components.  Lastly, our understanding of receptor binding has 
been complicated by the potential for VacA to interact with cells either as a monomer or 
as an oligomer.   
 
VacA oligomerization and pore-formation 
It is hypothesized that oligomerization is required for VacA pore-formation (105).  
VacA can assemble into a variety of water-soluble oligomeric structures, including 
single-layered hexamers and heptamers and double-layered structures consisting of 12 
or 14 subunits (60, 61, 106-109). The structures resemble ‘flowers’ in which a central 
ring is surrounded by peripheral ‘petals’  (Figure 3).  Similar oligomeric structures have 
been visualized on the surface of VacA-treated cells or lipid bilayers.  While the highest 
resolution images are 19 Å cryo-EM maps of water-soluble VacA dodecamers (107), 
atomic force microscopy studies suggest that membrane-associated VacA channels are 
probably single-layered structures (61).  Moreover, water-soluble VacA oligomeric 
complexes lack cytotoxic activity unless they are first dissociated into monomeric 
components by exposure to low pH or high pH conditions (98, 101, 106, 110).  
VacA can then insert into the plasma membrane to form channels (78), or can 
undergo endocytosis and eventually localize with late endocytic compartments or 
mitochondria (90, 111).  VacA-induced vacuoles correspond to swollen late endosomes, 
which are presumed to arise as a consequence of anion flux through VacA channels in 
the membranes of these compartments (58, 112).   
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Figure 3.  Structural analysis of H. pylori VacA toxin by cryo-negative staining EM.  
(top panel) Class averages resulting from 2D analysis of cryo-negatively stained VacA 
p88 particles showing well-contrasted six- or seven-sided forms.  (bottom panel)  
Refined 3D reconstructions of the dodecameric and tetradecameric forms.  Adapted 
from El-Bez et al. (107) 
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VacA domains 
Two domains of VacA, p33 and p55, have been identified based on partial 
proteolysis of p88 into fragments of 33 kDa and 55 kDa, respectively (Figure 2A) (73).  
When expressed independently and then mixed, p33 and p55 can reconstitute 
vacuolating toxin activity (113-115).  The N-terminal p33 domain (residues 1-311) 
contains a hydrophobic sequence (residues 6-27) involved in pore formation (105, 116), 
while the p55 domain (residues 312-821) contains one or more cell-binding domains 
(117-119).   Additionally, the m1/m2 allelic forms of VacA map to the p55 region.  When 
expressed intracellularly, the minimum portion of VacA required for cell-vacuolating 
activity comprises the entire p33 domain and about 110 amino acids from the N-terminus 
of p55 (115).  Amino acid sequences within both the p33 domain (residues 49-57) (120) 
and p55 domain (residues 346-347) (121, 122) are required for assembly of VacA into 
oligomeric structures, and mutant proteins lacking these sequences fail to cause cell 
vacuolation.  Several VacA mutant proteins have dominant-negative inhibitory effects on 
the capacity of wild-type VacA to cause cellular alterations (120, 123), which further 
supports the hypothesis that oligomeric structures are required for VacA effects on host 
cells.   
 
Research objectives  
 Herein, I describe structural, functional, and phylogenetic analyses used to 
assess the mechanisms by which VacA interacts with host cells.  Using X-ray 
crystallography, I found that the VacA m1 p55 domain adopts a β-helix fold that is 
characteristic of autotransporter passenger domains but unique among bacterial protein 
toxins (Chapter II).  Analysis of VacA sequence variation in the context of the structure 
has allowed me to propose new models about how receptor binding and oligomerization 
occur (Chapter II).  Efforts to obtain structural information on the VacA p33 domain 
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responsible for pore formation have been hindered by the insolubility of p33.  Recently, 
Christian Gonzalez, a student in Dr. Cover’s lab, has made progress in refolding the p33 
domain from inclusion bodies.  Christian and I have been collaborating to show that this 
refolded protein is well ordered and functional (Chapter III) and have developed a 
tractable path for crystallographic studies (Chapter V, Future Directions).  Finally, the 
elongated β-helical structure of VacA presents a unique opportunity for studying the 
pressures of positive and negative selection in a structural context.  I collaborated with 
Dr. Seth Bordenstein and Dr. Timothy Cover to study the evolution of VacA at the 
phylogenetic level (Chapter IV).  We have demonstrated that amino acid substitutions in 
VacA are under strong, diversifying selection.  Moreover, we describe divergence of 
VacA sequences into groups with distinct geographic distributions, which suggests 
independent bouts of VacA adaptive evolution within different human populations.  
Together, these studies have significantly advanced our understanding of the structural 
and functional correlates of VacA sequence diversity and mechanism. 
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CHAPTER II 
 
 
CRYSTAL STRUCTURE OF THE HELICOBACTER PYLORI  VACUOLATING TOXIN 
P55 DOMAIN 
 
 
 
Introduction   
 
 
Analysis of H. pylori strains isolated from unrelated humans indicates a high level 
of genetic diversity among vacA alleles (17, 63, 124, 125).  Although frequent 
recombination events have eliminated phylogenetic structure from the 5’ region of vacA 
alleles (17, 125), phylogenetic analysis of sequences from a vacA midregion indicates 
the existence of two large families of sequences, termed m1 and m2 (see Figure 1, 
Chapter I) (63, 124).  Within this ~281-aa midregion, the amino acid sequences of types 
m1 and m2 VacA proteins are only ~55% identical.  Differences in cell-type specificity 
have been noted for types m1 and m2 VacA proteins, a phenomenon that may result 
from binding of m1 and m2 VacA proteins to different cell-surface receptors (68, 126-
128).  With the exception of a few m1/m2 chimeras, there has been little evidence of 
recombination between m1 and m2 vacA alleles within the vacA midregion, and, 
therefore, a phylogenetic distinction between m1 and m2 VacA sequences has remained 
intact (124).  This distinction is the basis for a widely used typing scheme for H. pylori 
isolates (63, 124) and is relevant clinically because m1 strains are associated with 
gastric cancer (70).  To gain insights into the structural features of VacA that contribute 
to its cell-binding properties and to better understand the structural correlates of VacA 
sequence variation, we set out to determine the structure of the VacA p55 domain.   
 In this study, we determined a crystal structure of the VacA p55 domain refined 
to 2.4-Å resolution.  The structure is predominantly a right-handed parallel β-helix.  We 
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analyzed VacA protein sequences from unrelated H. pylori strains, including m1 and m2 
forms of VacA, in the context of the structure and identified structural features of the 
VacA surface that may be important for interactions with host receptors.  Furthermore, 
we docked the p55 structure into a 19-Å cryo-EM map of a VacA dodecamer and 
proposed a model for how VacA monomers assemble into oligomeric structures capable 
of membrane channel formation.   
 
Methods 
 
Expression and Purification of p55.  A plasmid encoding the p55 domain of VacA from H. 
pylori strain 60190 (a type m1 form of VacA; GenBank accession number Q48245) with 
an N-terminal hexahistidine tag (113) was transformed into E. coli BL21(DE3).  Cultures 
were grown at 37 °C overnight with shaking in Terrific broth (TB) supplemented with 50 
ug/ml of Kanamycin (KAN).  Overnight cultures were diluted 1:100 in fresh TB-Kan and 
grown at 37 °C for 2.5 h to an OD600 of 0.6-0.7.  Isopropyl-β-D-thiogalactopyranoside 
(IPTG) was added to a final concentration of 0.6 mM, and the proteins were allowed to 
express for 20 h at 23 °C.   Harvested cells were resuspended in lysis buffer (50 mM 
KPhosphate, 300 mM NaCl, 20 mM imidazole at pH 8.0) using a pre-chilled Dounce 
homogenizer and lysed by three passages through a pressure dispersion homogenizer 
at 20K psi.  Cell lysates were centrifuged at 20K rpm (48,000 x g) for 20 min at 4 °C.  
Wildtype p55 was purified by Ni-affinity, ion exchange and gel filtration chromatography 
and concentrated to 5.5 mg/ml in a 100 mM NaCl, 50 mM KPi buffer.   The sizing column 
retention time suggested a molecular weight of ~130 kDa.   We hypothesize that this 
result reflects the presence of an elongated p55 dimer.  Seleno-methionine p55 was 
produced from E.coli BL834(DE3) in a minimal medium (M9 salts plus glucose, amino 
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acid supplements, vitamins and minerals) in which 40 mg/liter L-cysteine and L-seleno-
methionine were added.  Purification methods for seleno-methionine p55 were similar to 
those used for the native protein, except 1 mM DTT and 5 mM methionine were 
incorporated to all buffers before affinity chromatography.  
Crystallization and Preparation of Heavy Atom Derivatives.  The native and seleno-
methionine p55 were concentrated in a 100 mM NaCl, 50 mM KPhosphate buffer and 
crystallized at 21 °C by the hanging-drop vapor diffusion method in which protein and 
precipitant were mixed in a 1:1 ratio.  Crystals grew from starting protein concentrations 
of 5.5 mg/ml and reservoirs containing 18-23% PEG1500 (Figure 4A).  Heavy atom 
derivatives were prepared by soaking crystals in 50 mM potassium tetrabromoplatinate 
(IV) (K2PtBr6) for 3 d, 5 mM 1,4-diacetoxymercuri-2,3-dimethoxybutane for 24 h, or 5 mM 
gold chloride (HAuCl4) for 24 h.  Crystals were mounted on cryo loops, sequentially 
soaked in cryoprotectant solutions containing 25% PEG1500, and 5%, 10%, and 15% 
glycerol, and flash-cooled in liquid nitrogen.   
Structure Determination and Refinement. X-ray data were collected from single crystals 
at 100 K on beamline ID-22 at the Advanced Photon Source (Argonne, IL) by using a 
MAR300 Image Plate Detector.  All the diffraction data were indexed, integrated, scaled, 
and merged with HKL2000 (Figure 4B, Table 1) (129).  Native and derivative crystals 
were spacegroup P3221 and had unit cell dimensions of a=b=57 Å and c=260 Å.  
Phases were determined by MIRAS using a native protein crystal and seleno-
methionine, platinum, mercury, and gold derivatives (Table 1).  Heavy atom positions 
were located and refined with the autoSHARP program suite (130).  The structure was 
subjected to iterative rounds of model building in O (131) and refinement in CNS (132) 
before applying TLS refinement (133) in REFMAC (134).  The refined model 
(Rcryst=18.1%, Rfree=22.2%) consists of amino acids 355-366, 377-811 and 206 water 
molecules.  SDS-PAGE and N-terminal sequence analysis of dissolved crystals 
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indicated that proteolysis had occurred at the N-terminus of p55 during crystallization, 
thus explaining the absence of residues 312-354 and 367-376 from the crystal structure.  
Proteolysis could be prevented by the addition of protease inhibitors, but crystals did not 
form under these conditions. 
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Figure 4.  Crystals of VacA p55 diffract to 2.4 Å.  (A) Crystals of the VacA p55 domain 
can be grown reproducibly in hanging drops to dimensions of ~ 200 x 150 x 50 µm.  
Crystals grow from precipitate after 10 days in 18-23 % PEG1500.  (B) The crystals 
diffract to 2.4 Å resolution at the APS synchrotron X-ray source.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20  
Table 1.  X-ray data collection and refinement statistics 
 
Outer resolution bin statistics are given in parentheses. 
*Rmerge = Shkl(Si|Ihkl,i - <Ihkl>))/Shkl,i<Ihkli>, where Ihkl,i is the intensity of an individual 
measurement of the reflection with Miller indices h, k, and l, and <Ihkl> is the mean 
intensity of that reflection.  
†Rcryst = S||Fobs,hkl| - |Fcalc,hkl||/|Fobs,hkl|, where |Fobs,hkl| and |Fcalc,hkl| are the observed and 
calculated structure factor amplitudes. Rfree is equivalent to Rcryst but calculated with 
reflections (5%) omitted from the refinement process.  
‡Calculated with the program PROCHECK (135).  
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Results and Discussion 
 
 
Crystal structure of the VacA p55 domain 
 
The crystal structure of the VacA p55 domain was determined to a minimum 
Bragg spacing of dmin = 2.4 Å using experimental phases from multiple isomorphous 
replacement and anomalous scattering (Table 1).  The p55 structure is predominantly a 
right-handed parallel β-helix (residues 355-735) but has a small globular domain at the 
C-terminus (residues 736-811) with mixed α/β secondary structure elements (Figure 5).  
The structure resembles a ‘sock’ in which the C-terminal domain curves from the ‘heel’ 
and extends to the tip of the ‘foot’.  The β-helical ‘calf’ is 65 Å long with widths of 25-31Å, 
while the C-terminal ‘foot’ is approximately 13 x 17 x 42 Å.  In the crystal, pairs of p55 
molecules meet at their N-terminal strands about a crystallographic two-fold axis (Figure 
6).  This packing is consistent with the elution of p55 as a dimer from gel filtration 
columns (see Methods) and a previous EM study indicating that a p55 domain secreted 
by H. pylori formed dimers (118).  VacA lacks sequence homology with other known 
proteins but is structurally similar to other β-helix protein structures.  The closest 
structural homologs, as assessed by the three-dimensional search algorithm DALI, are 
the inulin fructotransferase (2inu-A, Z = 13.9), P22 tailspike protein (1tyv, Z = 13.1), and 
the autotransporter protein P.69 pertactin (1dab-A, Z = 12.5).   
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Figure 5.  VacA p55 structure.  (A) The VacA p55 fragment adopts a β-helix structure 
that is composed of three parallel β-sheets (red) connected by loops of varying length 
and structure (yellow).  The α-helix in blue (α1) is contained within one of these loops but 
is highlighted in blue to show how it caps the end of the β-helix.  The C-terminal domain 
(green) has a mixture of α/β secondary structure elements and contains a disulfide bond 
(red) not previously observed in an autotransporter passenger domain structure.  A few 
of the secondary structural elements are labeled to serve as landmarks and correlate to 
sequences depicted in Figure 12.  (B) The C-terminus of the β-helix is capped by a β-
hairpin from the C-terminal domain (green) and the α1 α-helix (blue) located in one of 
the long β-helix loops.  This view represents a rotation of the molecule in a by ~90 ° into 
the plane of the page.   
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Figure 6.  The VacA p55 dimer forms an elongated β-helical structure.  Gel filtration 
and electron microscopy (118) indicate that VacA p55 exists as a dimer in solution.  
While the p55 protein crystallized with one molecule per asymmetric unit, a two-fold 
symmetry axis was present that revealed an extended β-helix structure formed from a 
head-to-head assembly of two molecules (red and green).  The fact that p88 does not 
form dimers suggests that this interface (boxed) is occluded by p33.  We propose that 
p33 adopts a β-helix structure that extends from the N-terminal end of p55.   
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Comparison of the VacA p55 structure with structures of other autotransporter 
passenger domains 
 Crystal structures have been determined for two other type Va autotransporter 
passenger domains: pertactin (an adhesin from B. pertussis) and Hbp (a hemoglobin 
protease from E. coli).  Pertactin (136), Hbp (137), and VacA p55 do not share sequence 
similarities but all contain a β-helix fold (Figure 7).  The β-helix fold is composed of 
multiple ~25 amino acid quasi-repeats, each of which forms a single rung of the helix 
(Figure 8).  Each rung contains three β-strands and three turn regions named β1, T1, β2, 
T2, β3 and T3 in their order of occurrence.  β1 and β2 are antiparallel β-strands and β3 
is approximately perpendicular to β2.  Conservation of the β-helix fold among 
autotransporter passenger domains suggests that this structural feature is required for 
efficient secretion across the outer membrane and folding (138).  Specifically, folding 
studies with pertactin indicate that the β-helix can form slowly but reversibly in solution, 
without aggregation, and with the formation of a stable core in the C-terminal half of the 
β-helix (138).  The C-terminal region of BrkA, an autotransporter whose structure is 
predicted to resemble that of pertactin, was shown to mediate BrkA folding, even when 
added in trans (139).  A C-terminal β-helix cap may be important as a nucleus and/or 
chaperone for secretion and folding (139).  These observations are consistent with 
current models of AT transport across the outer membrane (OM) in that they suggest the 
passenger domain can remain unfolded without aggregation in the periplasm, that the 
protein can fold in a C- to N-terminal fashion once threaded through the OM, and that 
the C-terminal β-helix cap is an important nucleus for proper folding.  The end of the 
VacA p55 β-helix is capped by a β-hairpin, similar to that observed in the structure of 
pertactin (136).  There is also a short α -helix in this region of VacA that appears to be 
unique among β -helix structures (Figure 5B).    
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Figure 7.  Passenger domain structures.  Ribbon diagrams of the passenger domains 
from three autotransporter structures:  Hbp (a hemoglobin protease from E. coli), 
pertactin (an adhesin from Bordetella pertussis) and VacA.  β-strands are yellow, loops 
are green, and helices are red.  Adapted from Barnard et al. (140).    
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Figure 8.  Nomenclature of the rungs from parallel β-helix proteins.  A rung of VacA 
p55 domain is shown and viewed down from the parallel β-helix axis.  The chain enters 
the coil from the T1 loop region.  The three parallel β-strands and the turns between 
them from a single rung are shown and named β1, T1, β2, T2, β3 and T3.   
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A notable difference between VacA p55 and the two other autotransporter 
passenger domain structures is the presence of a disulfide in the p55 C-terminal sub-
domain (Figure 5B).  The low cysteine content observed in autotransporter sequences is 
consistent with a model in which passenger domains translocate across the outer 
membrane in an unfolded conformation.  Nevertheless, a number of autotransporter 
sequences have a single, closely-spaced pair of cysteines near the C-terminus of their 
passenger domains (66).  In VacA, these cysteines are either 11 or 13 amino acids 
apart.  Mutation of either of these cysteines to serine results in a decrease in toxin 
secretion but has no effect on the vacuolating activity of the toxin (66) and (M. McClain, 
unpublished results).  Here, we show experimentally that these cysteines form a 
disulfide and that they are positioned to buttress both the β-helix cap and a conserved C-
terminal pocket (discussed below).  Finally, another feature of p55 that differs from other 
autotransporter passenger domains is the presence of multiple kinks that disrupt what 
would otherwise be continuous β-sheets.  We have divided the VacA p55 β-helix into 
five sub-domains to reflect these disruptions (Figure 9) and note that the divisions 
correlate with predicted sites of homologous recombination (as discussed further below). 
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Figure 9.   The VacA p55 structure reveals marked disruptions in β-sheet contacts. 
(A) Breaks in the β-sheet contacts (depicted with double-headed arrows) result in sub-
domains (SD) within the β-helix: SD-1 (red, 355-454), SD-2 (orange, 455-493), SD-3 
(yellow, 494-615), SD-4 (purple, 616-647), SD-5 (blue, 648-735).  The C-terminal 
domain and disulfide bond are colored green and red, respectively, and the site of the 
m2 23 amino acid insertion is indicated by an asterisk.  (B) This schematic shows 
prototype m1 and m2 VacA proteins (strains 60190 and Tx30a, respectively) and two 
naturally occurring m1m2 chimeras.  The breaks in β-sheet contacts (A) correlate with 
sites of homologous recombination (see also Figure 13).  In this schematic the mid-
region that distinguishes type m1 and type m2 sequences is colored 
orange/yellow/purple/blue (m1) or black (m2). 
 
 
 
A 
B 
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Sequence variation among VacA proteins   
In an effort to understand how genetic differences between m1 and m2 vacA 
alleles relate to structural and functional differences in the proteins they encode, we 
have examined VacA sequence polymorphisms in the context of the p55 structure.  We 
identified sequences for 62 m1 and 27 m2 VacA proteins in GenBank that were 
complete in the p55 region.  In addition, we identified 3 m1/m2 chimeric VacA proteins 
for which sites of recombination between m1 and m2 sequences were easily 
recognizable.  We aligned these sequences in various combinations using the program 
ClustalW (141) and mapped the sequence similarity scores to the three-dimensional m1 
p55 structure using ESPript (142).  The majority of residues pointing into the interior of 
the β-helix are either strictly or highly conserved, consistent with the idea that mutation 
of buried residues would result in a detrimental loss of structure and, therefore, function 
(Figure 10).  The surface-exposed residues are also fairly conserved when exclusively 
m1 or exclusively m2 sequences are analyzed (Figure 11).  However, when m1 and m2 
sequences are analyzed together, the surface-exposed residues are highly variable 
(Figure 12).  There are only two regions of the surface with notable sequence 
conservation.  One is located at the N-terminus (Figure 12A) and will be discussed in the 
next section with respect to protein oligomerization.  The second conserved surface is 
located at the C-terminus of the β-helix in a cavity formed by two loops (residues 668-
678 and 730-734) and the disulfide-linked C-terminal domain (Figure 12B).  The strict 
sequence conservation, the fact that many binding sites are located in clefts or cavities, 
and the fact that this is the only cavity observed in the VacA p55 structure, suggest that 
this area may represent a receptor binding site that is shared by m1 and m2 forms of the 
toxin.   
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Figure 10.  Alignment of m1 and m2 sequences mapped to the structure of VacA 
p55 from strain 60190 (an m1 sequence).  62 m1and 27 m2 sequences were aligned 
to that of VacA from m1 strain 60190 and scored with a Risler matrix according to the 
extent of sequence variation.  Scores were displayed on the p55 structure with a color 
ramp (red, orange, yellow, green, light blue, dark blue) in which strictly conserved 
residues are colored red, and the most variable residues are colored dark blue.  Residue 
side chains are shown as sticks.  The color-ramp of the alignment scores indicates a 
high level of sequence conservation of residues pointed in the interior of the β-helix with 
low sequence conservation for surface-exposed residues.  This view represents a 
rotation of the molecule into the plane of the page, from N- to C-terminus, looking down 
the β-helix.   
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Figure 11.  Alignment of exclusively m1 or exclusively m2 sequences mapped to 
the structure of VacA p55 from strain 60190 (an m1 sequence).  (A) 49 m1 
sequences were aligned to that of VacA from m1 strain 60190 and scored with a Risler 
matrix as described in Figure 10.  The color-ramp of the alignment scores indicates a 
high level of sequence conservation among m1 strains.  The central stripe of sequence 
diversity corresponds to β26, β29, and loop residues 597-600.  (B) 27 m2 sequences 
were aligned to each other for calculating an alignment score and to the sequence of m1 
VacA from strain 60190 for the purpose of displaying those scores on the three-
dimensional structure of m1 VacA p55.  While the m1 structure is not an entirely 
accurate representation of the m2 surface structure due to the presence of the 23 amino 
acid insertion and other sequence variations in the m2 mid-region, the analysis suggests 
that the surfaces of VacA proteins from m2 strains will be very similar.   
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Figure 12.  The VacA p55 structure has two patches of conserved residues.  (A) 62 
m1, 27 m2, and 3 m1/m2 chimeric VacA sequences were aligned and scored as 
described in Figure 10.  One conserved region is at the N-terminus of the protein 
(boxed) and correlates to the β3, β6, and β9 strands of the β-helix.  We propose that this 
surface is important for VacA oligomerization.  (B) Rotation of the molecule in view (A) 
by ~180˚ around the long axis of the protein reveals the second conserved region of the 
VacA p55 structure.  This surface is located in a pocket at the C-terminus of the β -helix 
(circled) and may represent a common receptor-binding site for all m1 and m2 VacA 
proteins.  The pocket is formed by two long β -helix loops (red) and the disulfide bond 
(also in red) of the C-terminal domain.  While the asterisked region is also highly 
conserved, this correlates to the N-terminal end of the β-helix that we predict to be 
buried when p33 is present. 
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Because multiple surface-exposed regions are highly divergent, it is difficult to 
identify a single region in the p55 structure that can explain the different binding 
properties of m1 and m2 VacA proteins (Figure 12).  The biggest difference between m1 
and m2 sequences is the presence of a 23 amino acid insertion in m2 sequences 
(Figure 9A, asterisk; and Figure 13).  The insertion is notable in that its sequence is an 
imperfect repeat of the sequence located immediately upstream, and the length 
approaches the average length of a single β-helix rung (~25 amino acids) (Figure 13).  
The 23 amino acid m2 insertion could therefore result in an additional β-helix rung, 
similar in structure to the rung that precedes it.  Based on an analysis of engineered 
m1/m2 chimeras, a region important for m1-specific binding to HeLa cells has been 
mapped to residues 460-496 in the m1 sequence (126).  The m2 23 amino acid insertion 
is located within this region, but an engineered chimera in which these 23 m2 amino 
acids were inserted into an m1 sequence did not result in a loss of HeLa cell toxicity.  
Excluding the m2 insertion, there are only ten amino acids in the 460-496 m1 sequence 
that consistently differ between the m1 and m2 forms (Figure 13).  The position of these 
residues in the context of the 23 amino acid m2 insertion is impossible to predict, and 
therefore, an understanding of structural features that give rise to VacA cell-type 
specificity may need to await analysis of an m2 p55 structure.   
 Analysis of the VacA sequence alignments in the context of the m1 p55 structure 
reveals that disruptions of β-sheet contacts within the β-helix correlate with sites of 
homologous recombination events.  For example, VacA residue D455 (strain 60190) 
represents the beginning of the mid-region that defines m1 and m2 strains (Figure 9B 
and Figure 13) and follows a kink in the structure that disrupts β-sheet contacts between 
β8 and β11 (Figure 9A and Figure 13).  This structural disruption and the associated 
sequence transition are illustrated with a change from red to orange (Figure 9 and Figure 
13).  Other examples of a correlation between VacA sub-domains and recombination 
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events are evident based on analysis of rare naturally occurring m1/m2 chimeras, which 
have m1 character in the N-terminal portion of the VacA mid-region but m2 character in 
the C-terminal portion.  The transition point from m1 to m2 in the chimeric VacA from 
strain 249a3 is at D493, while the transition point for the ch2 and v225 strains of VacA is 
at N616 (Figure 9B and Figure 13).  As illustrated in Figure 9A, these sequence 
transitions correlate with disruptions in β-sheet contacts between β14 and β17 and 
between β29 and β32, respectively.  The final sub-domain begins at residue G648.  
While we did not identify a sequence with evidence of recombination at this site, the sub-
domain (blue) has longer loops than other sub-domains and does not make β-sheet 
contacts with β33 from the previous sub-domain (Figure 9A).  
In summary, the polymorphisms that differentiate m1 and m2 forms correspond 
almost entirely to surface-exposed residues.  Diversification in these surface-exposed 
regions of VacA may have been driven by immune selective pressures.  Recombination 
occurs commonly in H. pylori (17, 125), but m1/m2 chimeras are only rarely identified 
(124).  This suggests that H. pylori strains with intact m1 or intact m2 VacA sequences 
have favorable functional properties, and thus, have a selective advantage compared to 
strains containing chimeric m1/m2 sequences (68, 126, 127).  The rare naturally 
occurring m1/m2 chimeras shown in Figure 9B and Figure 13 probably arose as the 
result of recombination events that maintained favorable structural and functional 
properties, due to recombination at sites corresponding to breaks in the β-helix. 
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Figure 13.  Alignment of m1, m2 and m1/m2 chimeric VacA sequences reveal sites 
of homologous recombination.  VacA sequences correspond to GenBank accession 
numbers Q48245 (60190), Q9KJA6 (ch2), Q6DLS8 (249a3) and Q48253 (Tx30a).  The 
numbering corresponds to the VacA sequences from strain 60190.  Consensus 
sequences, based on the analysis of 62 m1 and 27 m2 sequences, are also shown.  The 
secondary structural elements are identified as β (β-strand), TT (tight turn or kink), ŋ 
(310-helix), or α (α-helix).  Sequences were aligned in CLUSTALW (141) and displayed in 
ESPript (142).  Strictly conserved residues are shown in white letters with a black 
background.  Residues that are similar are boxed in bold letters with white backgrounds.  
The linkage between the p33 and p55 domains of VacA is sensitive to protease and 
thought to adopt a flexible loop structure since p33 and p55 remain associated after 
cleavage.  The first residue of p55, defined as K312 (red arrow), may also reside in a 
flexible loop as the N-terminal portion of p55 (circled in red) was removed by proteolysis 
during crystallization.  The first residue observed in the crystal structure was T355 
(second red arrow). Residue D455 (where orange color begins) represents the 
beginning of the mid-region that defines m1 and m2 strains.  The most notable feature of 
m2 strains is a 23 amino acid insertion between residues G475 and I476 of strain 60190 
(orange circle).  This insertion is an imperfect repeat of the preceding sequence (starting 
at residue D455) and is absent in both of the m1/m2 chimeric strains.  The first residue 
where the chimeric VacA from strain 249a3 begins to adopt m2 character aligns to N493 
of strain 60190.  The sequence that follows is colored yellow to highlight this transition.  
The first residue where the chimeric VacA from strains ch2 and v225 begins to adopt m2 
character aligns to G616 of VacA strain 60190.  (Only the ch2 sequence is shown for 
clarity.)  The sequence that follows is colored purple to highlight this transition.  The 
structure is colored in blue from 648-734 to indicate the fifth sub-domain of the β-helix.  
The C-terminal domain is colored green.   
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Assembly of VacA into oligomeric structures 
In order to understand the p55 structure in the context of VacA oligomers, we 
have docked p55 into the 19 Å cryo-EM map of the wild-type dodecamer (107) using the 
program COLORES (Figure 14A) (143).  The elongated shape of the β-helix and the 
curve of the C-terminal ‘foot’ allow for unambiguous placement of 12 p55 subunits into 
the ‘petal-like’ features of the map.  The docking suggests that contacts between the p55 
components of the two hexameric layers are mediated by three loops and that the N-
terminal end of the p55 β-helix extends into the central density of the map (Figure 14B).  
The conserved pocket that we propose as a potential common receptor binding site for 
m1 and m2 forms of VacA is located on the sides of the ‘petals’ and would be fully 
accessible to cell-surface receptors when VacA is assembled in either a single-layered 
or double-layered oligomeric structure (Figure 14B).   
We hypothesize that a large portion of p33 will adopt and extend the β-helix fold 
observed in p55.  This idea is supported by two observations.  First, an extended β-helix 
structure is consistent with the shape of a p88 monomer obtained by EM (Figure 14C, 
inset) (107).  Second, the program BetaWrapPro identifies the stretch of amino acids 
between residues 120 and 249 as a five-coil β-helix and predicts additional β-helix 
strands in the region between 252 and 288 (144).  BetaWrapPro uses profile wrapping 
for prediction and comparative modeling of β -helices and has been shown to identify the 
β-helix motif with high sensitivity and selectivity (144).   
Based on our prediction that a large portion of p33 will extend the β-helix fold 
observed in p55, we suggest a model in which VacA oligomerization is mediated by 
contacts between p33 and the N-terminus of p55 from a neighboring subunit (Figure 
14C).  Specifically, one would predict the p55 oligomerization surface to contain the β-
strands β3 and β6.  The surface-exposed residues of β3 and β6 are accessible within 
the central density of the EM map and are strictly conserved among the 92 m1 and m2 
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sequences we surveyed, suggesting selective pressure to preserve this surface (Figure 
14B).  An important functional role of this region is also supported by biochemical data 
indicating that VacA residues 1-422 can induce vacuolation in cultured cells when 
expressed intracellularly but p33, p55, and VacA residues 1-394 cannot (115, 122).  
Finally, this model is supported by a yeast two-hybrid experiment in which p33 and 
residues 313-478 of p55 were shown to interact (114).  The oligomerization surface may 
also contain parts of the flexible loop (312-354) that was not visible in this structure.  
Much of this loop is strictly conserved among the m1 and m2 VacA sequences (Figure 
13). 
p33 (residues 1-311) contains a putative α-helical pore-forming domain at its N-
terminus (116, 145).  Comparison of the VacA wild-type and Δ6-27 dodecamer 
structures by cryo EM suggests that the N-terminal domain of p33 is located in the 
central density of the structure (107).  Secondary structure prediction analyses suggest 
that p33 has α-helical structural elements between residues 1 and 71 (144).  Short β -
strands are then predicted to begin at residue 87 and extend through a region (residues 
120-288) that is predicted to have a β-helical structure, based on BetaWrapPro.  We 
therefore anticipate that a single subunit of VacA will adopt a roughly symmetric shape 
within the context of the oligomer and that residues in the N-terminal region of p33 (likely 
C-terminal to the pore-forming region) would be positioned to mediate oligomerization 
with the N-terminal region of a neighboring p55 subunit (Figure 14C).  
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Figure 14.  Docking the p55 crystal structure into a 19Å cryo-EM map of the VacA 
dodecamer results in a model for oligomerization.  (A) 12 p55 subunits are shown 
docked into a 19Å cryo-EM map of a VacA dodecamer.  An arrow is shown to indicate 
the space that the blue molecule will occupy if p33 extends the β-helix structure of p55.  
(B) The view in (A) is rotated by 90˚ such that the blue molecule moves toward the 
reader and is now located on the bottom of the dodecamer.  The blue molecule is not 
visible in this side view, however, because the view has been sliced so that only the 
‘back’ of the structure is visible.  On the left, a blue circle highlights three loops that 
mediate p55-p55 contacts between the two layers.  Circled in green are the two loops 
that line the conserved pocket that we propose as a common receptor-binding site.  This 
pocket is located on the side of the molecule and would therefore be accessible in both 
single layered and bilayered forms of the toxin.  The black circle contains the other 
conserved surface in p55 (also shown in Figure 12A).  This surface protrudes into the 
central ring of the VacA oligomer and would be accessible to the blue molecule in (A) for 
contacts that could mediate oligomerization within a hexameric or heptameric plane.  We 
have zoomed in on the secondary structures that contribute to this surface.  (C) We 
propose an oligomerization model in which p33 interacts with the N-terminal portion of 
p55 from the neighboring subunit.  Regions of contact between p33 and p55 are 
depicted with dashed lines.  The inset shows EM images of a VacA hexamer and a 
VacA monomer.  The shape of a VacA hexamer (inset) is similar to the shape of a single 
layer within the dodecamer The rod-like shape of the p88 VacA monomer (inset) 
supports a model in which the β-helix observed in p55 will extend into p33.  
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A protective H. pylori vaccine would potentially reduce the incidence of H. pylori 
infection and the serious complications of peptic ulcer disease and gastric 
adenocarcinoma (146), but the high level of diversity among H. pylori strains and the 
high frequency of genetic recombination among strains are likely to present significant 
challenges to vaccine development.  VacA is a candidate vaccine antigen since 
immunization with VacA confers protective immunity in a mouse model of H. pylori 
infection (146, 147).  We show here that two VacA surfaces are strictly conserved 
among all surveyed m1 and m2 sequences and propose that these surfaces are under 
selective pressure to be preserved in order to mediate receptor binding and 
oligomerization functions.  Efforts to selectively target these regions could result in 
progress toward the development of a vaccine that confers protection against multiple 
strains of H. pylori. 
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CHAPTER III 
 
 
RECONSTITUTION OF HELICOBACTER PYLORI VACA TOXIN FROM PURIFIED 
COMPONENTS 
 
 
 
Introduction 
 
 
The 88 kDa VacA monomers secreted by H. pylori can assemble into large 
water-soluble oligomeric complexes. These flower-shaped structures can be either 
single-layered (containing 6-9 subunits) or bilayered (containing 12-14 subunits) (60, 
106, 107, 109).  Similar oligomeric structures have been visualized on the surface of 
VacA-treated cells or lipid bilayers (60-62).  Amino acid sequences within both the p33 
domain (residues 49-57) and p55 domain (residues 346-347) are required for assembly 
of VacA into these oligomeric structures, and mutant proteins lacking these sequences 
fail to cause cell vacuolation (120, 121).  Several VacA mutant proteins have dominant-
negative inhibitory effects on the ability of wild-type VacA to cause cellular alterations 
(105, 120, 123), which further supports the hypothesis that oligomeric structures are 
required for VacA effects on host cells.  Water-soluble VacA oligomeric complexes lack 
cytotoxic activity unless they are first dissociated into monomeric components by 
exposure to low pH or high pH conditions, which suggests that VacA monomeric 
components reassemble into membrane channels when in contact with host cells (61, 
72, 78, 79).   Although the structure of water-soluble VacA oligomeric complexes has 
been investigated in detail, the conditions that promote oligomerization of VacA are not 
well understood.   
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While an X-ray crystal structure for p55 exists (Chapter II) and p88 oligomers 
have been visualized by cryo-electron microscopy (60, 107), a detailed analysis of p33 
has been hindered by an inability to purify this domain in an active form.    In this study, 
we expressed and purified a recombinant form of p33 under denaturing conditions and 
optimized conditions for the refolding of soluble protein.   We show that refolded p33 can 
be added to purified p55 in trans to cause vacuolation of HeLa cells and inhibition of IL-2 
production by Jurkat cells, effects identical to those produced by the p88 toxin secreted 
from H. pylori.  The p33 protein markedly enhances the cell-binding properties of p55.  
Size exclusion chromatography experiments suggest that p33 and p55 assemble into a 
complex consistent with the size of a p88 monomer.  Electron microscopy reveals small 
rod-shaped structures that can convert to oligomeric flower-shaped structures in the 
presence of detergent.   We propose that the ability to reconstitute a functional VacA 
toxin from two purified fragments in trans is facilitated by the elongated β-helical 
structure of VacA. 
 
Methods 
 
Purification of p88 VacAfrom H. pylori broth culture supernatant.  H. pylori strain 60190 
was grown in broth culture and VacA was purified from the culture supernatant as 
described previously (60, 107). 
Plasmids for expression of p33 and p55 VacA fragments.   Plasmids encoding the p33 
and p55 domains of VacA from H. pylori strain 60190 (a type m1 form of VacA; GenBank 
accession number Q48245), as well as a p33∆6-27 mutant protein, have been described 
previously (114, 123, 148). The p33 proteins contain a C-terminal hexahistidine tag and 
the p55 protein contains an N-terminal hexahistidine tag.   
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Expression and purification of recombinant VacA proteins. VacA p55 was purified as 
described previously (148).  VacA p33 was expressed in E. coli BL21 (DE3) by culturing 
in TB (Fisher) supplemented with 25 µg of Kanamycin/ml (TB-KAN) at 37 °C overnight 
with shaking. Cultures were diluted 1:100 in TB-KAN and grown at 37 °C until they 
reached an OD600 of 0.6. Cultures were induced with a final IPTG concentration of 0.5 
mM and incubated at 37 °C for 2 hours (114).   
 VacA p33 proteins were purified from inclusion bodies. Briefly, IPTG-induced 
cultures were pelleted, washed in 0.9% NaCl, and resuspended (10 ml per liter of 
culture) in sonication buffer  [10 mM Tris pH 7.5, 100 mM NaCl, 1 mM EDTA, a protease 
inhibitor tablet, and lysozyme 20,000 U/ml (Ready-lyse, Epicentre)]. The cells were 
incubated at room temperature for 15 minutes with shaking, and sonicated with six 20 
watt bursts (45 seconds per burst with 15 s cooling periods).  Lysed bacterial cells were 
centrifuged to pellet the inclusion bodies.  The insoluble inclusion body pellet was 
resuspended in buffer containing 100 mM NaH2PO4, 10 mM Tris, and 8 M urea (pH 8.0) 
at 5 ml per gram wet weight, and incubated for 1 hour at room temperature. The 
samples were centrifuged, and the resulting supernatant was added to Ni-NTA beads 
(Novagen) at a ratio of 4 ml of supernatant per 1 ml of beads. The protein-bead mixture 
was incubated for 1 hour at room temperature before loading it into a column and 
allowing it to flow by gravity. The column was washed with 10 column volumes of 100 
mM NaH2PO4, 10 mM Tris, 10 mM imidazole, and 8 M urea (pH 6.3), followed by 100 
mM NaH2PO4, 10 mM Tris, and 8 M urea (pH 5.9). The p33 protein was eluted from the 
column with 100 mM NaH2PO4, 10 mM Tris, and 8 M urea (pH 4.5).   Successful 
expression and purification of p33 was confirmed by mass spectrometry. 
Refolding of VacA p33.  The denatured VacA p33 protein was refolded by dialyzing the 
protein against a buffer containing 55 mM Tris, 21 mM NaCl, 0.88 mM KCl, 1.1 M 
guanidine, and 880 mM arginine (pH 8.2) for 24 hours. The protein then was dialyzed in 
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two other buffers, each for 24 h.  The first reduced the guanidine to 800 mM and the 
arginine to 500 mM, and the second reduced the arginine to 250 mM and maintained an 
800 mM guanidine concentration (149). Further reductions in the arginine or guanidine 
concentrations resulted in precipitation of p33 VacA.  The dialyzed protein was then 
centrifuged and filtered (0.2 micron) to remove any insoluble protein.  
Cell culture assays.  HeLa cells were grown in minimal essential medium (modified 
Eagle’s medium containing Earle’s salts) supplemented with 10% fetal bovine serum 
(FBS) in a 5% CO2 atmosphere at 37ºC. Jurkat lymphocytes (clone E6-1) (ATCC TIB-
152) were grown in RPMI 1640 medium containing 2 mM L-glutamine, 1.5 g/liter sodium 
bicarbonate, 4.5 g/l glucose, 10 mM HEPES and 1.0 mM sodium pyruvate supplemented 
with 10% FBS in a 5% CO2 atmosphere at 37 °C.  
For vacuolating assays, HeLa cells were seeded at 1.2 x 104 cells/well into 96-
well plates 24 hours prior to the addition of VacA proteins. The recombinant p33 and p55 
proteins (each at 1 mg/ml) were pre-mixed at a 1:1 mass ratio.  Preparations of p33, p55 
or the p33/p55 mixture were then added to the tissue culture media overlying HeLa cells 
(supplemented with 10 mM ammonium chloride) at concentrations of 10 µg/ml (or 5 
µg/ml of each protein in the case of the p33/p55 mixture) for 9 hours at 37 °C. After 
incubation, cell vacuolation was examined by inverted light microscopy and quantified by 
neutral red uptake assay (150).  For dominant negative assays, refolded p33 ∆6-27 
protein was mixed with the refolded p33/purified p55 mixture (1 mg/ml each) in a 1:1:1 
mass ratio and added to the tissue culture media overlying the cells at a final protein 
concentration of 10µg/ml for 9 hours at 37 °C, and vacuolation was quantified (123). 
To analyze the capacity of VacA to inhibit IL-2 secretion by Jurkat T cells, Jurkat 
cells were plated at 1 x 105 cells/well, and the recombinant p33 and p55 were added to 
cells either individually or as a p33/p55 mixture (1:1 mass ratio) at concentrations of 6 
µg/ml (or 3µg/ml in the case of the p33/p55 mixture), which corresponds to about a 1.7:1 
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molar ratio, for 30 minutes at 37 °C.  The use of excess p33 on a molar basis 
compensated for the possibility that refolding of denatured p33 might be less than 100% 
efficient.  After incubation, 0.05 µg/ml of phorbol 12-myristate 13-acetate (PMA) and 0.5 
µg/ml of ionomycin were added for 24 hours at 37°C. The cells were then centrifuged at 
2,000 rpm for 7 minutes and the supernatants were tested for IL-2 by ELISA, according 
to the manufacturer’s protocol (R&D Systems Human IL-2 Immunoassay) (151).     
Interactions of p33 and p55 with HeLa cells.  Purified p55 was labeled with Alexa 488 
(Molecular Probes) according to the manufacturer’s instructions.    HeLa cells were 
incubated with Alexa 488-labeled p55 alone (10 ug/ml) or a mixture of labeled p55 plus 
purified refolded p33 (5 ug/ml of each) at 37 °C degrees.  Alternatively, cells were 
incubated with purified Alexa 488-labeled p55 plus purified refolded c-Myc-tagged p33 
protein (113). Cells were fixed with 4% formaldehyde.  To detect the c-Myc-tagged p33 
protein, cells were permeabilized with methanol, and the c-Myc tag was detected by 
indirect immunofluorescence using anti-c-Myc antibody and a Cy3-conjugated 
secondary antibody.  Cells were viewed with an LSM 510 confocal laser scanning 
inverted microscope.  
Size exclusion chromatography.  Gel filtration was performed using eitherSuperdex 200 
10/300 GL high-resolution resin or Superdex 200 10/300 prep grade resin, equilibrated 
in 55 mM Tris (pH 8.0), 21 mM NaCl, 0.88 mM KCl, 800 mM guanidine, and arginine 
(either 800 mM or 250 mM).     Protein samples (500 µl) were first injected onto the gel 
filtration column individually at a final concentration of 0.75 mg/ml for the p33 protein and 
0.4 mg/ml for the p55 protein.  To analyze p33/p55 mixtures, the appropriate sizing 
column fractions corresponding to either p33 or p55 were each concentrated to 1 mg/ml.  
VacA p33 was added to p55 in a 2:1 v/v ratio, the mixture incubated for 45 minutes at 4 
°C, and the p33/p55 mixture was then applied to a gel filtration column.  Retention 
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volumes of bovine thyroglobulin, alcohol dehydrogenase, bovine serum albumin, and 
carbonic anhydrase were used as standards to calculate the molecular masses of the 
purified VacA proteins. 
Electron microscopy.  To visualize the morphology of p33/p55 mixtures, appropriate gel 
filtration fractions containing these proteins were analyzed by electron microscopy (EM) 
using conventional negative staining as described (152).   Protein solutions were diluted 
to appropriate final concentrations (25 to 100 µg/ml) and 2.5 µl aliquots were spotted 
onto glow-discharged copper-mesh grids (EMS) for approximately 1 min.   In some 
experiments, p33/p55 mixtures were mixed 9:1 (v/v) with Brucella broth (153), bovine 
total heart extract (Avanti) solubilized in chloroform (25 mg/ml), chloroform, or n-dodecyl 
beta-D-maltoside (DDM, Anatrace) prior to EM analysis.  The final concentration of DDM 
was 0.34 mM, which corresponds to twice the critical micelle concentration.  The grids 
were washed in 5 drops of water followed by one drop of 0.7% uranyl formate.  Grids 
were then incubated on one drop of 0.7% uranyl formate for 1 min, blotted against filter 
paper and allowed to air dry. Images of wild-type p88 or p33/p55 mixed with Brucella 
broth, DDM, chloroform, or bovine heart lipids in chloroform were recorded using a FEI 
morgagni run at 100 kV at a magnification of 36,000X. Images were collected on ATM 
1Kx1K CCD camera. Images of p88 used for multi-reference alignment were collected 
on a FEI 120 KV electron microscope at a magnification of 67,000X. Images were 
recorded on DITABIS digital imaging plates (Pforzheim, Germany). The plates were 
scanned on a DITABIS micron scanner (Pforzheim, Germany), converted to mixed raster 
content (mrc) format, and binned by a factor of 2 yielding final images with 4.48 Å/pixel. 
Images of p33/p55 in DDM purified by gel filtration were taken on a 200 kV FEI electron 
microscope equipped with a field emission electron source and operated at an 
acceleration voltage of 120 kV at a magnification of 100,000X. Images were collected 
using a Gatan 4Kx4K CCD camera. CCD images were converted to mrc format and 
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binned by a factor of 4 resulting in final images with 4.26 Ǻ/pixel. Images of both p88 and 
p33/p55 were taken under low-dose conditions using a defocus value of –1.5 um.   
For alignment and averaging of p88 VacA and p33/p55 VacA in DDM, 9,871 and 
1,273 images of p88 and p33/p55 VacA particles, respectively, were selected with Boxer 
and windowed with a 120 pixel side length (154).  Image analysis was carried out with 
SPIDER and the associated display program WEB (155).  The images were rotationally 
and translationally aligned and subjected to 10 cycles of multi-reference alignment and 
K-means classification.  For analysis of p88 VacA, alignment particles were first 
classified into 20 class averages and 7 representative classes then were chosen as 
references for another cycle of multi-reference alignment. For analysis of p33/p55 VacA, 
alignment particles were first classified into 10 class averages and then four 
representative projections were chosen as references for another cycle of multi-
reference alignment.  
 
Results 
 
 
Expression, purification and refolding of recombinant p33 VacA 
In previous studies, it has not been possible to purify a functionally active form of 
the p33 domain (113).  We attempted to purify the p33 VacA from E. coli extracts under 
native conditions but were unsuccessful.  Therefore, we expressed and purified the 
recombinant p33 under denaturing conditions and then used dialysis to reduce the 
concentration of denaturants and allow the protein to refold.  After the p33 protein was 
refolded, it eluted as a well-defined peak by size exclusion chromatography (Figure 15).    
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Figure 15.  Purification of recombinant p33 VacA.   SDS-PAGE and Coomassie blue 
stain of p33 VacA purified under denaturing conditions (inset).  Gel filtration 
chromatography (Superdex 200 10/300 GL high-resolution resin) of p33 VacA after 
protein refolding, using buffer containing 800 mM guanidine and 800 mM arginine, as 
described in Methods.      
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Refolded p33 mixed with purified p55 causes cellular alterations  
To test the activity of the purified p33 and p55 proteins, we added these proteins 
individually and in combination to HeLa cells, and analyzed the capacity of the proteins 
to cause cell vacuolation, a hallmark of VacA activity.  No detectable vacuolating activity 
was observed when the p33 or p55 protein was added to cells individually, as 
demonstrated by neutral red uptake and light microscopic examination of the cells 
(Figure 16A).  Similarly, none of the buffers alone or in combination exhibited any 
detectable activity.  In contrast, a mixture of the purified p33 and p55 proteins caused 
extensive vacuolation of HeLa cells (Figure 16A and 16B).  The potency of the p33/p55 
mixture was slightly lower than that of the p88 VacA protein purified from H. pylori broth 
culture supernatant (Figure 16B). A mixture of p55 plus heat-denatured p33 failed to 
cause any detectable effects on cells (Figure 17). 
 Previous studies have shown that VacA from H. pylori inhibits production of IL-2 
by Jurkat cells (88).  To test whether p33 and p55 proteins exhibit a similar activity, we 
incubated Jurkat cells with the purified p33 and p55 proteins individually and in 
combination.  When added individually, neither p33 nor p55 had any effect on IL-2 
secretion (Figure 16C). In contrast, the p33/p55 mixture inhibited IL-2 secretion from 
Jurkat cells (Figure 16C and Figure 16D).  The potency of the p33/p55 mixture was 
slightly lower than that of the p88 VacA protein purified from H. pylori (Figure 16D). 
Collectively, these results indicate that the refolded p33 is biologically active and is 
capable of causing alterations in eukaryotic cells. 
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Figure 16.  Effects of p33 and p55 VacA proteins on HeLa cells and Jurkat cells. 
Purified refolded p33 and purified p55 (each 1 mg/ml) were mixed together in a 1:1 mass 
ratio, which ensured an excess of p33 on a molar basis. The p88 VacA protein purified 
from H. pylori culture supernatant was acid-activated prior to contact with cells (106, 
110), whereas the p33 and p55 preparations were not acid-activated.  (A) HeLa cells 
were incubated with the purified VacA proteins at a final concentration of 10 µg/ml (or 5 
µg/ml of each protein in the case of p33/p55 mixture).  Cell vacuolation was quantified by 
neutral red uptake assay (OD 540 nm). (B) HeLa cells were incubated with the indicated 
final concentrations of a p33/p55 mixture (20 µg/ml corresponds to 10 µg/ml p33 and 10 
µg/ml p55), or the p88 form of VacA purified from H. pylori broth culture supernatant.  
Cell vacuolation was quantified by neutral red uptake assay.  (C) Jurkat cells were 
incubated with the indicated purified VacA proteins at a concentration of 6 µg/ml (or 3 
µg/ml of each protein in the case of the p33/p55 mixture) for 30 min at 37°C. The cells 
were then stimulated and IL-2 secretion was measured as described in Experimental 
Procedures. (D) Jurkat cells with the indicated were incubated with the indicated final 
concentrations of a p33/p55 mixture or the p88 form of VacA purified from H. pylori 
culture supernatant.   The cells were then stimulated and IL-2 secretion was measured 
as described in Methods. Results represent mean ± standard deviation, based on 
analysis of triplicate samples. 
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Figure 17.  Effects of denatured p33 and p55 VacA proteins on HeLa cells.  p33 
was refolded as described in Materials and Methods. Purified p55 and p33 (each 1 
mg/ml) were mixed together in a 1:1 mass ratio, which ensured an excess of p33 on a 
molar basis. HeLa cells were incubated with the indicated heat denatured purified VacA 
p33/p55, or untreated p33/p55 as a control, at a final concentration of 10 µg/ml. Cell 
vacuolation was quantified by neutral red uptake (OD 540 nm).  Results represent mean 
± standard deviation, based on analysis of triplicate samples. 
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Refolded p33 ∆6-27 exhibits a dominant negative effect  
When certain mutant VacA proteins (e.g. VacA ∆6-27) are mixed with wildtype 
VacA, the mutant proteins can act as dominant-negative inhibitors of wildtype VacA 
activity (67, 105, 120, 121, 123). To further validate the new methods for expression and 
refolding of p33 proteins, we expressed, purified and refolded the p33 ∆6-27 protein 
under the same conditions used for purification and refolding of the p33 wild-type 
protein.  When added to cells individually or in combination with purified p55, the p33 ∆6-
27 protein did not cause detectable cell vacuolation (Figure 18A).  To test for dominant- 
negative properties of the mutant protein, we pre-mixed the p33 ∆6-27 protein with 
p33/p55 mixtures that were known to be active (Figure 18A).  When this p33/p55/p33 
∆6-27 mixture was added to cells, no detectable vacuolation was observed, indicating 
that the mutant protein exhibited a dominant-negative effect (Figure 18B).  Thus, the 
purified refolded p33 ∆6-27 protein, when mixed with purified p55, exhibited dominant-
negative inhibitory properties similar to those of the p88 ∆6-27 protein.   
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Figure 18.  Refolded p33 ∆6-27 exhibits dominant negative properties. (A) VacA 
p33 ∆6-27 was purified and refolded as described in Experimental Procedures.  Purified 
p33 ∆6-27 was mixed with p55 and p33 (each 1 mg/ml) at a 1:1:1 mass ratio.  HeLa cells 
were then incubated with the indicated recombinant VacA proteins (either individually or 
in a mixture) at a final concentration of 10 µg/ml for 9 hours at 37oC. Cell vacuolation 
was quantified by neutral red uptake assay. (B) Wildtype p88 VacA (5 µg/ml) was 
incubated with the indicated concentrations of the VacA p33Δ6-27/p55 mixture or the 
p88 Δ6-27 VacA protein purified from H. pylori culture supernatant.  Cell vacuolation was 
quantified by neutral red uptake assay.  Results represent the mean ± standard 
deviation, based on analysis of triplicate samples. 
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Interactions of p33 and p55 with HeLa cells 
Several previous studies have shown that sequences within the p55 domain 
contribute to the binding of p88 VacA to cells, and it has been suggested that p55 
functions as a cell-binding domain (68, 118).  To investigate the cell-binding properties of 
p55 in further detail, we incubated HeLa cells with purified fluorescently-labeled p55.  
Very little if any interaction of purified p55 with HeLa cells was observed (data not 
shown).  In contrast, when p55 was incubated with HeLa cells in the presence of purified 
refolded p33, a marked increase in the binding and uptake of p55 by cells was observed 
(data not shown). Thus, p33 markedly enhanced the cell-binding properties of p55.  
Further studies indicated that when a mixture of p33 and p55 was incubated with cells, 
both p33 and p55 bound to the cell surface (data not shown). These properties of 
purified p33 and p55 proteins are consistent with previously observed properties of p33 
and p55 proteins contained in crude E. coli extracts (113). 
 
  
Interaction of refolded p33 with purified p55  
To investigate potential interactions among the purified p33 and p55 proteins, we 
performed size exclusion chromatography experiments. When the refolded wildtype p33 
protein was analyzed, a peak with a predicted mass of about 96 kDa was observed 
(Figure 19, red peak with star).  When the purified p55 protein was analyzed, a peak with 
an approximate molecular mass of 178 kDa observed (Figure 19, green peak with star). 
When the p33/p55 mixture was analyzed, a peak with a predicted mass of 86 kDa was 
observed (Figure 19, blue peak with star), the 96 kDa peak (corresponding to p33 alone) 
was lost, and the 178 kDa peak (corresponding to p55 alone) was minimized.    
Representative fractions were tested by SDS-PAGE and Coomassie blue staining; this 
revealed an approximate 33 kDa band for the VacA 96 kDa peak, a 55 kDa band for the 
178 kDa peak, and two protein bands of 33 kDa and 55 kDa for the 86 kDa peak (Figure 
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19B).   When tested in cell culture assays, the p33/p55 mixture corresponding to the 
blue peak in Figure 19 caused cell vacuolation with a potency similar to that shown in 
Figure 16.  Taken together, these results suggest that the refolded p33 protein interacts 
with the purified p55 protein to yield a p33/p55 complex.   Moreover, these data suggest 
that p33 oligomers and p55 oligomers must undergo disassembly in order to interact 
with each other and form 88 kDa p33/p55 complexes.    
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Figure 19.  Analysis of p33 and p55 proteins by gel filtration. (A) Size exclusion 
chromatography (Superdex 200 10/300 prep grade resin) of refolded p33 (red peak), 
purified p55 (green peak) or a mixture of the two proteins (blue peak). Refolded p33 and 
purified p55 (each 1 mg/ml) were mixed at a 2:1 mass ratio and injected into the sizing 
column, as described in Materials and Methods.  The buffer contained 800 mM 
guanidine and 250 mM arginine.  The inset shows retention volumes of p33, p55, and 
the p33/p55 mixture in comparison to standard proteins. (B) The lower-molecular-mass 
peaks (stars) from each of the size exclusion chromatography experiments shown in 
panel A were analyzed by SDS-PAGE and Coomassie blue staining.  
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Assembly of p33/p55 complexes into oligomeric structures 
The p88 VacA protein secreted by H. pylori can assemble into water-soluble 
oligomers (60, 106, 107, 109).   To investigate the possibility that p33 and p55 domains 
might assemble into similar structures, we visualized the p33/p55 mixture (purified by gel 
filtration as a monomeric complex) by EM.   VacA p88 oligomers purified from H. pylori 
culture supernatant (and exchanged into guanidine- and arginine-containing buffer by 
gel filtration) were analyzed as a control.   As expected, large flower-like structures were 
visualized in preparations of H. pylori p88 VacA (Figure 20A).   In contrast, the p33/p55 
mixture consisted mainly of small rod-like particles (Figure 20B), similar to the 
appearance of p88 monomers produced by H. pylori (106, 107).   
To explain why p88 proteins in H. pylori broth culture supernatant readily 
assemble into flower-like oligomeric structures whereas purified p33 and p55 proteins do 
not, we hypothesized that the broth culture medium used for growth of H. pylori (a 
nutrient-rich medium prepared from yeast extract and animal tissue, known as Brucella 
broth) might contain factors that promote VacA oligomerization.   To test this hypothesis, 
we examined the appearance of the p33/p55 mixture by EM, either in the presence or 
absence of added Brucella broth.   In the presence of added Brucella broth, increased 
formation of flower-shaped complexes was detected (Figure 20C).  These experiments 
indicated that Brucella broth stimulates the oligomerization of p33/p55 mixtures into 
oligomeric structures similar to those formed by p88 VacA from H. pylori. 
 
 
 
 
 
 58  
 
 
 
 
 
 
 
 
 
Figure 20.  Assembly of p33 and p55 proteins into oligomeric structures.  EM 
analysis of (A) p88 purified from H. pylori culture supernatant, and then exchanged into a 
guanidine-containing buffer by gel filtration, or (B) a mixture of refolded p33 and p55 
eluted from the sizing column (corresponding to Figure 19, blue peak with star).   The 
p33/p55 preparation shown in panel B was then mixed with different components as 
described in Methods and analyzed by EM.  (C) p33/p55 plus Brucella broth.  
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High-resolution imaging of p33/p55 oligomeric complexes 
We reasoned that the complex mixture of components in Brucella broth, including 
numerous membrane-derived factors, promoted the formation of flower-like oligomers.   
In an effort to stimulate VacA oligomerization using more refined conditions, we 
incubated p33/p55 mixtures with various additives designed to create an amphipathic 
environment, including bovine heart total extract solubilized in chloroform, chloroform 
alone, and detergent (DDM).   Each of these additives promoted oligomerization of the 
p33/p55 monomeric complexes into flower-like oligomeric structures.  The VacA 
oligomers formed in the presence of bovine heart extract or chloroform had a more 
heterogeneous appearance than the VacA oligomers formed in the presence of DDM, 
and therefore, we studied the latter oligomers in further detail.   To permit higher 
resolution imaging, p33/p55 monomeric complexes (corresponding to the 86 kDa blue 
peak in Figure 19) were mixed with detergent, dialyzed, and passed over a gel filtration 
column in the presence of detergent and arginine and absence of guanidine.  Under 
these conditions, the 86 kDa peak was minimized and a high-molecular mass (>300 
kDa) peak was observed.   High-molecular mass complexes containing wild-type p33 
and p55 were isolated and analyzed further by EM.   The appearance of these oligomers 
(Figure 21A) was similar to that of the p33/p55 complexes shown in Figure 20 and p88 
oligomers isolated from H. pylori broth culture supernatant (Figure 21B).  To further 
characterize the structural features of p33/p55 oligomers, approximately 1,300 particles 
were classified into 10 groups and four classes were chosen as references for an 
additional round of reference based-alignment (Figure 21C). To directly compare the 
structural organization of p33/p55 oligomers with that of p88 oligomers purified from H. 
pylori broth culture supernatant, class averages of p88 oligomers were also generated. 
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Because p88 oligomers seemed to adopt a larger number of conformations than 
p33/p55 oligomers, a larger number of p88 images were classified. Approximately 
10,000 particles of p88 VacA were classified into 20 class averages and seven classes 
were chosen for an additional round of reference based-alignment (Figure 21D). 
The result of the p33/p55 alignment (Figure 21C) shows that the majority of the 
p33/p55 oligomers are composed of six or seven subunits (67%, Figure 21C, panels 1 
and 2), with one smaller class composed of an oligomer with 12 visible subunits (22%, 
Figure 21C, panel 3), and one class representing poorly formed oligomers (Figure 21C, 
panel 4). The 12-subunit complex may represent a double-layered oligomer with the two 
layers splayed (60, 107). The overall appearances of hexameric and heptameric 
p33/p55 oligomers are reminiscent of single-layer hexameric and heptameric oligomers 
formed by p88 VacA (Figure 21D, panels 1 and 2) (60, 106, 107).   These single-layered 
oligomers exhibit a striking chirality, which suggests that one surface adsorbs 
preferentially to the support film.  In contrast to the p33/p55 oligomers, a majority of the 
p88 oligomers exist as double-layered complexes containing 12-14 subunits (77%, 
Figure 21D, panels 3 though 7) (60, 106, 107). Importantly, difference maps created 
between averages of p33/p55 and p88 single-layer heptameric and hexameric oligomers 
did not show any statistically relevant difference peaks, which indicates that these 
oligomeric forms are structurally equivalent. 
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Figure 21.  Analysis of p33/p55 VacA oligomers in negative stain. Mixtures of 
refolded p33 and p55 eluted from the sizing column (corresponding to Figure 19, blue 
peak with star) were mixed with DDM, and then dialyzed overnight in buffer containing 
55 mM Tris pH 8.0, 21 mM NaCl, 0.88 mM KCl, 250 mM arginine, and DDM.  The 
protein was passed over a gel filtration column that was equilibrated with dialysis buffer 
containing DDM, and VacA oligomers eluting in a high-molecular-mass fraction were 
then analyzed by EM.   (A) Representative image of negative stained p33/p55 VacA 
oligomers eluting in a high-molecular-mass fraction. Scale bar, 100 nm. (B) 
Representative image of negative stained p88 VacA oligomers isolated from H. pylori 
broth culture supernatant.  Scale bar, 100 nm. (C) Four class averages of p33/p55 VacA 
particles in negative stain generated from reference-based alignment.  The number of 
particles in each projection average is shown in the lower right corner of each average. 
Side length of individual panels is 511 Å. (D) Seven representative class averages of 
p88 VacA particles in negative stain generated from reference-based alignment.  The 
number of particles in each projection average is shown in the lower right corner of each 
average. Side length of individual panels is 538 Å. 
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Discussion 
 
 
 
In this study, we demonstrate that a functionally active form of H. pylori VacA can 
be reconstituted from two purified VacA fragments (p33 and p55).   Previously, the p55 
fragment was purified and its crystal structure determined (148), but it was not possible 
to purify a soluble, functionally-active form of p33.   In the current study, we purified the 
p33 domain under denaturing conditions and then employed a series of steps designed 
to allow the protein to refold and remain soluble.  We found that the refolded p33 protein 
was soluble in a buffer containing 800 mM guanidine and 250 mM arginine, but upon 
removal of these additives, the p33 protein became insoluble.  Nevertheless, in 
comparison to denatured p33, the refolded p33 protein exhibited functional activity when 
mixed with the p55 fragment, which suggests that the p33 protein was successfully 
refolded. 
Previous studies reported that a mixture of E. coli lysates containing VacA p33 
and p55 can cause vacuolation of HeLa cells (113), and intracellular co-expression of 
p33 and p55 in HeLa cells results in cell vacuolation (115, 122).   However, there are 
numerous limitations associated with the use of crude E. coli lysates or intracellular 
expression systems.    By using purified p33 and p55 proteins in the current study, we 
were able to monitor the process by which p33 and p55 proteins interact to yield a 
functionally active VacA protein.   Specifically, we demonstrate that the p33 and p55 
proteins were purified with molecular masses of about 96 kDa and 178 kDa, 
respectively.   The mass of the p33 protein is consistent with a trimeric form, but efforts 
to validate this by EM were unsuccessful.  The mass of the p55 protein is consistent with 
a trimer as well, but the crystal structure of p55 revealed a head-to-head packed dimer 
that adopts an elongated dumbbell shape (148). The elongated shape and the unusual 
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buffer conditions likely account for the high apparent molecular mass of p55 on the 
sizing column.  Upon mixing of the p55 and p33 preparations, the p55 and p33 homo-
oligomers each dissociated to yield a p55/p33 complex with a mass of about 86 kDa, 
corresponding to a complex containing one p55 subunit and one p33 subunit.  The 
monomeric complexes were visible by EM as elongated rods, consistent with the 
hypothesis that p33 extends the β-helix structure observed in p55 (148). 
The ability to reconstitute a functional protein from two individually-expressed 
component domains is somewhat unusual among bacterial protein toxins, and unusual 
among proteins in general.   This phenomenon is probably facilitated by the elongated β-
helical structure of VacA, a structural feature that is predicted to be shared by many 
autotransporter passenger domains (139, 148, 156).   The VacA p55 domain consists 
predominantly of a β-helix, composed of multiple ~25 amino acid repeats, each of which 
forms a 3 β-strand triangle-shaped rung (148).  Adjacent coils are held together by 
backbone hydrogen bonds.   The β-helix is therefore very different from globular proteins 
where adjacent structural elements are held together with an intricate arrangement of 
sidechain interactions.  Based on computer modeling, the VacA p33 domain is also 
predicted to comprise a β-helical structure, and it is predicted that the p88 protein 
comprises an elongated continuous β-helical structure (148).  In the current experiments, 
we speculate that the C-terminal coil of p33 interacts with the N-terminal coil of p55, 
recapitulating the structural relationship that exists between these two domains in the 
intact p88 VacA protein (148).   If generally true, the ability to assemble proteins in trans 
using a β-helical packing motif could have exciting implications for the generation of 
novel protein functionalities. 
A distinctive property of the p88 VacA protein secreted by H. pylori is its ability to 
assemble into water-soluble, flower-shaped oligomeric structures (60, 106, 107, 109).  In 
the current study, we observed that purified p33 and p55 proteins interact to form ~86 
 64  
kDa complexes, but do not readily assemble into oligomeric structures when maintained 
in buffer alone.  One possible explanation is that the guanidine and arginine constituents 
of the buffer (required for maintenance of p33 solubility) prevent VacA oligomerization; 
however, we observed that these agents did not cause disassembly of p88 oligomers 
purified from H. pylori culture supernatant.  We hypothesized that H. pylori broth culture 
supernatant might contain factors (either components of the rich Brucella broth medium 
used for culture of H. pylori, or additional H. pylori products) that allow VacA oligomers to 
form.  We observed that, indeed, the addition of freshly prepared Brucella broth (not 
previously cultured with H. pylori) to purified p33/p55 mixtures promoted assembly of 
VacA into oligomeric structures.  Similarly, the addition of detergent also stimulated 
oligomerization.  We speculate that oligomerization is stimulated by exposure to an 
amphipathic environment, and that the oligomerization observed in these experiments 
mimics the process by which VacA oligomerizes when in contact with membranes of 
host cells.   
The p88 VacA protein is typically purified in an oligomeric form from H. pylori 
broth culture supernatant (56, 60, 106, 107, 109), and monomeric forms of p88 VacA 
have been relatively difficult to purify.   When added to cultured eukaryotic cells, purified 
p88 VacA oligomers lack detectable activity in most assays unless the oligomers are first 
exposed to low pH or high pH conditions, which results in oligomer disassembly; 
oligomers have been observed to reassemble if the pH is returned to neutral (61, 78, 80, 
98, 101, 106, 110).   A current model presumes that VacA monomers interact with the 
cell surface, and then reassemble into oligomeric complexes that function as membrane 
channels.  In the current study, we demonstrate that a mixture of purified p33 and p55 
proteins is fully active in cell culture assays in the absence of low pH or high pH 
activation.  Since the p33/p55 mixture predominantly consists of a p88 complex (Figures 
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19 and 20), this provides additional support for a model in which VacA monomers 
interact with the plasma membrane.  
Several lines of evidence indicate that oligomerization of p88 VacA is required for 
VacA-induced cellular alterations.  Specifically, mutant forms of VacA that fail to 
oligomerize properly lack detectable activity in most cell-based assays (120, 121), and 
dominant-negative mutant forms of VacA interact with wild-type VacA and thereby 
abrogate wild-type VacA activity (67, 105, 120, 121).   VacA oligomerization is 
presumably required for membrane channel formation (61, 78, 79), and we speculate 
that oligomerization also may be required for VacA internalization.  Potentially 
oligomerization of VacA occurs preferentially within lipid raft components of the plasma 
membrane (62, 103, 157).   VacA oligomeric structures have been visualized on the 
surface of VacA-treated cells or lipid bilayers (60-62), and in contrast to double-layered 
oligomeric forms of VacA found in H. pylori culture supernatant, there is evidence that 
the VacA oligomeric complexes formed on the surface of cells are single-layered (61).  
In the current study, we observed that detergent promoted assembly of p33/p55 
mixtures into predominantly single-layered oligomeric structures.  Therefore, the 
complexes visualized in the current study are predicted to be useful models for VacA 
channels that form in the context of human cells.  
The reconstitution of VacA activity from purified p33 and p55 components 
probably involves a complex series of molecular events.   An initial step involves 
disassembly of p33 and p55 homo-oligomers and formation of a p33-p55 complex.   
Potentially the presence of p55 disrupts p33-p33 interactions, or the presence of p33 
may disrupt p55-p55 interactions.  An important observation is that neither p33 nor p55 
bound to cells when added individually, whereas the p33/p55 mixture exhibited binding 
to cells (data not shown).  One possible explanation is that the homo-oligomeric forms of 
p33 and p55 lack cell-binding activity, and cell-binding surfaces become exposed upon 
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disassembly of the homo-oligomeric complexes.  Alternatively, the receptor-binding 
site(s) may span both domains.   Finally, the assembly of p33/p55 complexes into 
higher-order flower-shaped oligomers may stabilize the interaction of VacA with the 
surface of eukaryotic cells, and also may be required for insertion of VacA into 
membranes and channel formation.        
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CHAPTER IV 
 
 
MOLECULAR EVOLUTION OF HELICOBACTER PYLORI VACUOLATING TOXIN 
(VACA) 
 
 
 
Introduction 
 
 
H. pylori strains from unrelated humans exhibit a high level of genetic diversity 
that is adapted for colonization of the human stomach (17, 18).  The population structure 
of H. pylori is panmictic, and the rate of recombination in H. pylori is reported to be 
among the highest in the Eubacteria (17, 33).  Multilocus sequence analysis of 
housekeeping genes has revealed the presence of at least nine different H. pylori 
populations or subpopulations that are localized to distinct geographic regions (158, 
159).  Analysis of these sequences suggests that H. pylori has spread throughout the 
world, concurrently with the major events of human dispersal, and thus H. pylori is 
potentially a useful marker for the geographic migrations of human populations (158). 
While the genetic diversity patterns are consistent with this theory, there has not yet 
been any formal phylogenetic assessment of the ancestry of H. pylori in human 
populations.   
All strains of H. pylori contain a chromosomal vacA gene, but individual strains 
differ considerably in levels of VacA activity (57, 63).   Genetic variation at this locus 
could be under strong selection as H. pylori adapts to the host immune response, 
colonizes new human hosts, or inhabits different host environments.  Previous 
phylogenetic studies analyzed relatively small numbers of vacA sequence fragments and 
focused mainly on analysis of nucleotide sequences rather than amino acid sequences 
(17, 63, 69, 124, 125, 160). Two studies analyzed vacA sequence encoding a fragment 
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of the p33 domain and did not detect any recognizable phylogenetic structure (star or 
bush type pattern), presumably due to the presence of extensive recombination (17, 
125).   Other studies analyzed different regions of VacA and detected polymorphisms 
that allow classification of vacA alleles into distinct families (designated s1/s2, i1/i2, or 
m1/m2) depending on the presence of signature sequences in different regions of VacA 
(63, 124, 161).   In general, strains containing vacA alleles classified as s1, i1, or m1 
have been associated with an increased risk of ulcer disease or gastric cancer 
compared to strains containing vacA alleles classified as s2, i2, or m2 (63, 70, 161).  
Geographic differences have been detected within several of these vacA regions (64, 
69, 162-164). 
 H. pylori strains that produce an active VacA protein (type s1 VacA) typically 
express CagA, and strains that produce inactive VacA proteins (type s2 VacA) typically 
lack the cagA gene (63).    vacA and the cag PAI localize to distant sites on the H. pylori 
chromosome, and therefore, the basis for this association has been unclear.  There are 
complex relationships between the cellular effects of VacA and CagA, whereby VacA 
can downregulate CagA’s effects on epithelial cells, or vice versa (165-168). This 
functional interaction between VacA and CagA may represent a mechanism that allows 
H. pylori to minimize damage to gastric epithelial cells or minimize mucosal 
inflammation, thereby allowing it to persistently colonize the stomach.   
In this chapter, we show that phylogenetic reconstructions of amino acid 
sequences specify three VacA groups with distinct geographic distributions.  Divergence 
of the groups is principally due to sequence changes in the p55 domain, a central region 
responsible for binding of the toxin to host cells.   Population genetic analyses specify 
that divergence of the p55 domain into three groups occurred by natural selection. The 
positively selected sites in the p55 domain map to surface-exposed residues in the VacA 
crystal structure.  Moreover, a phylogenetic tree for the virulence determinant CagA is 
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comprised of three groups that are phylogeographically-similar to those of the VacA tree, 
suggesting coevolution of VacA and CagA due to common selective pressure.  Finally, 
phylogenetic analysis of the origins of VacA using the close relative H. acinonychis as an 
outgroup reveals that the ancestry of VacA is strikingly different from the African origins 
that typify the core genome.  Taken together, these results indicate previously 
unrecognized positive selection and coevolution in the VacA and CagA virulence 
determinants of H. pylori. The correspondence of positively selected VacA sites to 
surface-exposed residues of p55 is consistent with immune-mediated positive selection, 
since antibody responses are directed against p55. 
 
Methods 
 
VacA sequences.  One hundred deduced VacA amino acid sequences (86 full-length 
gene sequences and 14 that were complete within the region encoding the p55 domain) 
were retrieved from Genbank.  These sequences originated from H. pylori strains that 
were isolated from humans in many different regions of the world.  To obtain additional 
VacA sequences of African origin, we analyzed vacA in five H. pylori strains that were 
isolated from patients in Africa and previously classified by MLST analysis as HpAfrica2 
(strains 191.9 and 501.9), HspSAfrica (cc2c) or HspW Africa (D1a and D1b) (158, 159).  
The vacA locus was amplified using Expand Long Template PCR System (Roche 
Applied Science) with the primers described in Table 2 and the vacA sequences were 
determined.  Sequences are deposited in GenBank (accession numbers pending).  The 
vacA sequences from strains D1a and D1b each contained a frameshift mutation and 
were excluded from subsequent phylogenetic analyses.  Sequences were aligned with 
MUSCLE and edited manually in MacClade 4.08 (169).  The total length of aligned 
sequences was 1354 amino acids.  All indels and hypervariable regions were removed, 
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resulting in a final alignment length of 1135 amino acids for the unrooted analysis and 
971 amino acids for the rooted analysis.  
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VacA reference sequences.  VacA from strain 60190 (Genbank accession no. Q484245) 
was used as the reference sequence for amino acid numbering, in which residue 1 
refers to alanine-1 of the secreted 88-kDa VacA protein.  It is the prototype s1/m1 form 
of VacA and the crystal structure of the p55 domain of VacA from this strain has been 
determined (148).   VacA from strain 95-54 (Genbank accession no. U95971) and strain 
Tx30a (Genbank accession no. Q48253) were used as reference sequences for s1/m2 
and s2/m2 proteins, respectively (63, 68).  
Criteria for classification of VacA sequences.  VacA sequences were classified as m1 or 
m2 based on the absence or presence, respectively, of a 21-amino-acid insert within the 
p55 domain (between amino acid 475 and 476) (Figure 13) (63).  We identified and 
excluded two m1/m2 chimeric VacA proteins (from strains ch2 and v225) in which tracts 
of recombination between m1 and m2 sequences were identifiable by eye.  VacA 
sequences were classified as s1 or s2, based on the absence or presence, respectively, 
of a 9 amino acid insertion in the signal sequence region (63).  VacA sequences were 
classified as i1 or i2, based on amino acid substitutions that fall into two clusters that 
have been previously denoted as cluster B and C (161).   
Phylogenetic analyses. The unrooted phylogenetic distance trees for VacA and CagA 
were created using the Neighbor Joining method with the Jukes Cantor genetic distance 
model in Geneious 4.6.5 (170). Support for nodes on the neighbor-joining tree was 
assessed by 2000-replicates of bootstrap, and the majority rule consensus tree is 
shown.   
Population genetic tests of selection.  A sliding window analysis of dN/dS ratios was 
performed using VacA sequences from strains 60190 (m1 type) and 95-54 (m2 type) 
with the program DnaSP (171).  Sliding window parameters included a window size of 
50 bases and a step size of 10 bases.  For further analyses, a total of 45 VacA 
sequences, corresponding to 15 VacA amino acid sequences from each VacA group, 
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were retrieved from Genbank.  These strains are shown (bold) in Figure 23.  
Additionally, a total of 32 CagA sequences, corresponding to CagA amino acid 
sequences from each CagA group (6 from Group 1, 15 from Group 2, and 11 from 
Group 3), were retrieved.   Sequences were assembled and aligned with Geneious and 
edited manually in MacClade 4.08 (169).  All indels and hypervariable regions were 
removed.  The McDonald-Kreitman test (172) was carried out on full-length vacA, 
individual regions of vacA, and full-length cagA sequences with the exclusion of low 
frequency variants less than or equal to 15% to reduce artifacts associated with 
detecting adaptive evolution.  Next, we investigated the codon sites under selection 
using the programs omegaMap (173) and PAMLv4.3 (174, 175). The Bayesian method 
implemented in omegaMap incorporates intragenic recombination and does not assume 
a known fixed genealogy, so that recombination does not inflate the false detection rate 
of positive sites. The same vacA sequences from the MKT were used in omegaMap (15 
sequences from each Group for a total of 45 sequences).  We used 500,000 Markov-
chain Monte Carlo samplings, and the first 50,000 iterations were discarded as a burn-in.  
The variable model was chosen with the average block length of 30 for both ω and ρ.  
One objective and one subjective approach to prior specification were used.  First, 
inverse distributions were used for ω and ρ, and improper inverse distributions were 
used for the other parameters (µ, κ, and φ).  Starting values for µ, κ, and φ were, 
respectively, 0.1, 1, and 1.  In the second approach to prior specification, exponential 
distributions were used for all parameters (starting values were µ =0.1, κ = 1, φ = 1, ω = 
1 and ρ = 0.001).  Two independent runs were performed and both runs converged.  For 
PAML, twelve full-length vacA sequences that encompass the range of genetic variation 
in VacA were selected for analysis.  Codons that were subject to positive selection were 
identified using Nsites models (M1a, M7) that do not permit positive selection compared 
to models (M2a, M8) that permit sites to evolve under positive selection.   
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Figure 22.  Ladderized version of the neighbor-joining VacA phylogenetic tree 
shown in Figure 23.  This diagram shows the taxa used in the analyses and their 
evolutionary relationships.  Single asterisks indicate taxa for which whole genome 
sequences are available; sequences from these strains were included in the MLST 
analysis and SH analysis (Figure 33 and Figure 35).  Double asterisks indicate taxa that 
were incomplete in the p33 or β-barrel region. Bold labeling indicates taxa used in the 
omegaMap and MKT analysis (Table 3).  The numbers represent posterior probability 
values for each node. 
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Reconstruction of a vacA pseudogene from H. acinonychis. The entire vacA 
pseudogene of H. acinonychis, corresponding to approximately nucleotides 443900 to 
439500 in the genome sequence of strain Sheeba (176), was translated in all 3 reading 
frames, and the translated fragments with homology to H. pylori VacA were then 
concatenated.  The VacA protein encoded by the reconstructed H. acinonychisvacA 
pseudogene consists of 1310 amino acids.  A BLAST search indicates that the 
reconstructed H. acinonychis VacA sequence exhibits 64% amino acid identity to its 
closest match in H. pylori and retains a high level of relatedness to H. pylori VacA 
throughout the entire sequence.  
MLST Analysis.   Nucleotide sequences were retrieved from the H. pylori multilocus 
sequence typing database (http://pubmlst.org/helicobacter).  This database contains 
sequence data (398 to 627 nucleotides per gene) for seven housekeeping genes (atpA, 
efp, mutY, ppa, trpC, ureI, yphC) (158).   Concatenated nucleotide sequences were 
aligned using MUSCLE and edited manually in MacClade 4.08 (169).  To permit rooting 
of an MLST tree, we retrieved orthologous sequences from the H. acinonychis genome 
(176).  PhyloBayes and MrBayes inference methods were used to generate the rooted 
MLST trees and posterior probability values.   
Rooted Phylogenetic Analyses of VacA sequences.  PhyloBayes 2.3 was used to infer 
phylogenetic relationships of the rooted tree based on PhyloBayes and MrBayes 
inference methods.  These analyses were performed with the site homogeneous models 
of Jones-Taylor-Thorton (JTT), and Whelan and Goldman (WAG), and the category 
amino acid site-heterogeneous mixture model (CAT) to suppress tree artifacts 
associated with long branch attraction (177).  For all PhyloBayes and MrBayes analyses, 
at least two independent runs were performed with free equilibrium frequencies inferred 
from the data and gamma distributed rate variation with four discrete categories.  Burn-
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ins up to 20% of the sampled trees were used until a maxdiff value < 0.15 was achieved 
to ensure chain equilibration. 
Shimodair-Hasegawa Test. We tested the significance of topological differences in VacA 
and MLST phylogenetic trees using the Shimodaira-Hasegawa (SH) test (178).  The SH 
test compares the likelihood score (-lnL) of a given data set across its ML tree versus the 
-lnL of that data set across alternative topologies, which in this case are the ML 
phylogenies for other data sets.  The differences in the -lnL values are evaluated for 
statistical significance using bootstrap (1000 replicates) based on RELL sampling. 
 
Results & Discussion 
 
VacA phylogeography     
An unrooted phylogenetic analysis of VacA protein sequences from 100 different 
H. pylori strains demonstrated three distinct groups (Figure 23 and Figure 24), 
corresponding to strains predominantly of Western origin (Group 1), Asian origin (Group 
2), or Western and Asian origin (Group 3).  Within Group 3 there is a subgroup of 4 
sequences (from strains CHN5147, CHN1811a, CHN5114a and CHN3295b; designated 
subgroup II), all of which were from H. pylori strains isolated in Shanghai, China (164).  
H. pylori strain Shi470, located in the tree between Group 1 Western and Group 2 Asian 
populations, was isolated from an Amerindian patient in the Amazon (179). We 
examined the sequences within each group to detect previously described VacA 
signature sequences (63, 124, 161).  Based on an analysis of indels (insertions and 
deletions, which were excluded when generating the tree) all of the sequences in Group 
1 and Group 2 were classified as type m1, and all of the sequences in Group 3 were 
classified as type m2 (Figure 23).  All of the VacA sequences in Groups 1 and 2 contain 
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a type s1 signal sequence region; three sequences within Group 3 contain a type s2 
signal sequence, and the remainder contain type s1 signal sequences (Figure 23).   
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Figure 23.  Analysis of VacA phylogeography.  (A) The vacA gene encodes a 140-
kDa protoxin, which undergoes cleavage to yield a signal sequence, a secreted 88-kDa 
toxin, a secreted alpha peptide, and a C-terminal β-barrel domain.  The mature 88-kDa 
VacA toxin contains two domains, designated p33 and p55.  The midregion sequence 
that defines type m1 and m2 forms of VacA is located within p55.  A 21-amino acid 
insertion is present in m2 forms, but not m1 forms of VacA.  (B) Neighbor-joining 
phylogenetic tree of 86 complete amino acid sequences and 14 partial sequences of 
VacA. Three major groups are evident. The chart shows the number of strains analyzed 
and characteristics of VacA sequences in each group of the tree.  Group 1 comprises 
type m1 sequences mainly from strains of Western origin, Group 2 comprises m1 
sequences of Asian origin and Group 3 comprises m2 sequences of both Asian and 
Western origin.    
 
 
 
 
 78  
Analysis of VacA structural domains 
Next we performed phylogenetic analyses restricted to five putative structural 
domains of VacA (Figure 23A):  p55, signal sequence region, p33, secreted alpha 
peptide (SAP), and the C-terminal β-barrel region (Figures 24, 25, 26, 27, and 28).  The 
tree for the p55 domain (427 aligned amino acids) yielded a three-group pattern (Figure 
24) that overlaps with the phylogeography of full-length VacA (Figure 23B).  The other 
regions exhibited tree structures (see Figures 25-28) substantially different from those of 
full-length VacA or p55 trees.  The phylogenetic structure of the signal sequence domain 
(Figure 25) is consistent with data reported in previous studies, reflecting a divergence 
between s1 and s2 forms of VacA and the presence of several s1 subtypes (s1a, s1b, 
s1c).   In our analysis of the p33 domain, most of the sequences localized within a single 
group (Group 1), but 14 sequences were highly divergent (Group 2) (Figure 26).  This 
branching pattern reflects differences within the intermediate region (type i1 and i2).  The 
sequences in p33 Group 1 are characterized as type i1, with the exception of two 
sequences that appear to be i1-i2 hybrids, and sequences in p33 Group 2 are 
exclusively characterized as type i2. The branching pattern observed in an analysis of 
the p33 domain (Figure 26) is strikingly different from the results published in previous 
studies that analyzed ~500 bp of nucleotide sequences encoding a fragment of the p33 
region; these previous studies described a single “star” pattern, and detected extensive 
recombination that obliterated any phylogenetic structure (17, 125).  The phylogenetic 
structures of the alpha peptide and C-terminal β-barrel region (Figure 27 and Figure 28, 
respectively) have not been previously investigated, but distinct groups were also 
detected within these trees.  Phylogenetic trees of the p55 domain, SAP, and beta-barrel 
domain each contained groups that comprised exclusively sequencess of East Asian 
origin.   Other features of the phylogenetic structures, such as the divergence of m1 and 
m2 sequences within the p55 region, were independent of geography.  Based on the 
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phylogeography patterns of the other domains, we can conclude that the localization of 
full-length VacA sequences to three main groups (Figure 23) is determined primarily by 
sequence divergence in the p55 region (Figure 24). 
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Figure 24.  Neighbor-joining phylogeny of the VacA p55 domain.  Three main 
groups are detected within this tree, designated Groups 1-3.  The chart shows the 
number of strains analyzed and characteristics of VacA sequences in each group of the 
tree.  This tree maintains the same pattern as the VacA full-length tree shown in Figure 
1.  The nomenclature for the primary VacA p55 groups (Groups 1, 2, and 3) is consistent 
with the nomenclature of groups in the full-length VacA tree (Figure 23). 
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Figure 25.  Neighbor-joining phylogeny of VacA signal sequences.  This tree is a 
ladderized tree revealing three main groups (Groups A-CSignal Sequence).  The phylogenetic 
structure of the signal sequence domain is consistent with data reported in previous 
studies (63), reflecting a divergence between s1 and s2 forms of VacA and the presence 
of several s1 subtypes (s1a, s1b, s1c).   Group ASignal Sequence contains three sequences 
that are highly divergent from all of the other sequences; these three sequences contain 
an insertion characteristic of type s2 VacA signal sequences, whereas all of the others 
lack this insertion (type s1).  Group BSignal Sequence contains s1a and s1c sequences, 
whereas Group CSignal Sequence contains exclusively s1b sequences.  In agreement with 
previous reports (63, 64), we detected five amino acid differences between subtype s1a 
and s1b sequences.  Subtype s1c differs from subtype s1a at two amino acid positions 
and differs from s1b at seven positions.  Type s1c sequences were detected exclusively 
in Asian strains and type s1b sequences were detected predominantly in Western 
strains.   
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Figure 26.  Neighbor-joining phylogeny of the VacA p33 domain.  Two main groups 
are evident, designated Group Ap33 and Group Bp33. The chart shows the number of 
strains analyzed and characteristics of VacA sequences in each group of the tree.  The 
sequences in Group Ap33 were localized in Groups 1, 2, 3 of the full-length VacA tree 
(Figure 23), and sequences in Group Bp33 were all localized in Group 3 of the full-length 
VacA tree.  Divergence between Group Ap33 and Group Bp33 reflects differences within 
the VacA intermediate region (161).  The sequences in Group Ap33are characterized as 
type i1, with the exception of two sequences that appear to be i1-i2 hybrids, and 
sequences in Group Bp33are exclusively characterized as type i2.  
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Figure 27.  Neighbor-joining phylogeny of the VacA secreted alpha peptide (SAP) 
domain.  The phylogeny of the alpha peptide region has not been previously 
investigated, but distinct groups are detected within this tree, designated Groups A-CSAP.  
The chart shows the number of strains analyzed and characteristics of VacA sequences 
in each group of the tree.  The SAP phylogenetic tree contains 3 groups that reflect the 
geographic origin of strains (two groups are predominantly from strains of Asian origin 
and one group is predominantly of Western origin) (Groups A-CSAP).  Group ASAP 
corresponds to a mixture of the strains in Groups 1 and 3 of full-length VacA tree (Figure 
23), Group BSAP corresponds to Group 3 of the full-length tree, and Group CSAP 
corresponds to Groups 2 and 3 of the full-length tree.   
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Figure 28.  Neighbor-joining phylogeny of the VacA C-terminal β-barrel domain. 
The phylogeny of the C-terminal β-barrel region has not been previously investigated, 
but four distinct groups are detected, designated Groups A-Dβ-barrel.  The chart shows the 
number of strains analyzed and characteristics of VacA sequences in each group of the 
tree.  The β-barrel phylogenetic tree contains 4 groups that reflect the geographic origin 
of strains (two groups are predominantly from strains of Western origin and two groups 
are predominantly of Asian origin) (Groups A-Dβ-barrel).  Group Aβ-barrel corresponds to a 
mixture of the strains in Groups 2 and 3 of full-length VacA (Figure 23), Group B β-barrel 
corresponds to Group 3 of the full-length tree, Group C β-barrel consists of a mixture of 
strains from Groups 1 and 3 of the full-length tree, and Group D β-barrel consists of mainly 
strains from Group 1 of the full-length VacA tree. 
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Sliding window and McDonald-Kreitman tests   
A relatively high level of divergence within the p55 VacA cell-binding domain 
compared to other domains may reflect relaxed constraint on that portion of the 
sequence or positive selection if amino acid replacements confer a selective advantage. 
In the latter case, we expect to observe an accumulation of nonsynonymous changes at 
a rate higher than that of synonymous changes (dS).  To investigate the evolutionary 
pressures acting on VacA, we first analyzed vacA sequences for positive selection 
(dN/dS > 1) using a sliding window analysis with full-length vacA sequences from strains 
60190 (type m1 Western, Group 1) and 95-54 (type m2, Group 3). The crystal structure 
of the p55 domain is available for VacA from strain 60190 (148), and VacA from strain 
95-54 is known to exhibit a different cell-type specificity compared to VacA from strain 
60190 (68). dN /dS ratios greater than one were observed in mainly one portion of the 
vacA sequence - the p55 cell-binding domain (Figure 29).  
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Figure 29.  Sliding window analysis of VacA from H. pylori strains 60190 and 95-
54.  VacA sequences from strains 60190 (Western m1 type) and 95-54 (Western m2 
type) were aligned and dN/dS ratios were calculated using DnaSP with a sliding window 
of 50 bases and a 10-bp step size.  dN/dS > 1 indicates positive selection. 
 
 
 
 
 
 87  
To follow up the initial observation of elevated dN/dS ratios in the portion of vacA 
encoding the p55 cell-binding domain, we collected full-length DNA sequences of 15 
vacA alleles from each of the three main groups (Groups 1-3, Figure 22).  We used the 
McDonald-Kreitman test (MKT) (172) to investigate if adaptive evolution in the p55 
domain is driving the divergence of the three groups. The MKT analyzes the neutral 
theory prediction that the ratio of synonymous-to-nonsynonymous polymorphism (Ps/Pn) 
within groups should be the same as the ratio of synonymous-to-nonsynonymous 
divergence (Ds/Dn) between groups, and was used previously to detect positive 
selection in an H. pylori sel1 homolog (180).  The results indicate a significant deviation 
from neutrality when analyzing full-length vacA sequences and the p55 domain (Table 3) 
(p < 0.001), but not when analyzing the p33 domain or other regions.  Excess 
nonsynonymous fixation, one signature of adaptive protein evolution, causes the 
Neutrality Index (NI) in the MKT to be less than 1.  For all statistically-significant MKT 
comparisons, the NI was < 0.53.   These results confirm the sliding window analysis and 
indicate that the divergence in the p55 cell-binding domain is in part due to strong 
positive selection.  
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Table 3.  Analysis of positive selection in vacA using the  
McDonald-Kreitman Test.      
                
Domain of VacA Dn Ds Pn Ps 
p-
value NI
1 α-value2 
        
Group 2 (m1 Asian) vs. Group 3 (m2)          
Full-length 146.06 68.03 248 286 0 0.408 0.591 
   Signal Sequence 0 0 17 19 N/A N/A N/A 
p33 0 0 57 75 N/A N/A N/A 
p55 153.49 75.68 99 92 0.001 0.53 0.469 
   SAP 1 0 22 22 0.322 0 1 
β-Barrel 0 0 72 100 N/A N/A N/A 
        
Group 1 (m1 Western) vs. Group 3 (m2)        
Full-length 132.02 63.09 353 393 0 0.429 0.57 
   Signal Sequence 0 0 21 19 N/A N/A N/A 
p33 3 2.01 78 104 0.446 0.501 0.498 
p55 130.93 61.1 143 140 0 0.476 0.523 
   SAP 3.02 3.07 33 29 0.862 1.157 -0.157 
β-Barrel 1 1 78 101 0.856 0.774 0.225 
                
Group 2 (m1 Asian)  vs. Group 1 (m1 Western)      
Full-length 46.51 31.81 194 314 0 0.422 0.577 
   Signal Sequence 0 0 12 16 N/A N/A N/A 
p33 4.01 5.08 31 75 0.348 0.523 0.476 
p55 32.64 17.62 70 110 0.001 0.343 0.656 
   SAP 6.08 2.03 27 29 0.154 0.311 0.688 
β-Barrel 4.01 7.18 54 84 0.828 1.15 -0.15 
                
1 The Neutrality Index (NI) was calculated from the ratio NI = (Pn/Ps)/(Dn/Ds), where 
P = polymorphic within the population, D = divergence or fixed difference between 
populations, n = nonsynonmous, and s = synonymous.   
2 α-value is the proportion of adaptive substitutions that ranges from -∞ to 1 and is  
estimated as 1-NI. 
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Codons under selection in VacA 
We next used the program PAML to detect specific amino acids experiencing 
positive selection.  We aligned and analyzed the p55 region-encoding sequences of 12 
vacA genes that encompass the genetic diversity in the unrooted phylogenetic analysis 
(Figure 30A).  Models that allow codons to evolve under positive selection (M8 and M2a) 
fit the dataset significantly better than do models that do not permit positive selection 
(M7 and M1a) (p < 0.0001, Figure 30B).  The M1a vs. M2a analysis identified 14 amino 
acids that were undergoing positive selection and seven were significantly selected 
(posterior probability > 0.85).  All seven were surface-exposed in the p55 domain crystal 
structure (Figure 30C) and localized to regions identified by the sliding window analysis 
(Figure 29), signifying that adaptive evolution is potentially due to selection for receptor-
binding determinants that mediate VacA interactions with host cells or immune escape.  
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Figure 30.  Positive selection within the vacA p55 domain identified by PAML and 
omegaMap.  (A) Neighbor-joining tree of VacA sequences selected for the PAML 
analysis. (B) Summary of amino acid sites in the p55 domain that are under positive 
selection, based on PAML analysis.  Results obtained using two models (M1a vs. M2a 
and M7 vs. M8) are shown. (C) Three-dimensional structure of the p55 domain from H. 
pylori strain 60190, with positively-selected amino acids identified in the former PAML 
analysis, mapped in color (posterior probability > 0.85, green or > 0.95, red).  The p55 
domain crystal structure comprises residues 355 to 811.  Residue 667 is labeled in 
magenta and is the amino acid that both PAML and omegaMap determined to be under 
significant positive selection (posterior probability > 0.95). Residues E799, N800, G801 
are labeled in blue and are the additional residues in the type m2 VacA sequences 
(Group 3) that omegaMap determined to be under significant positive selection. 
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Selection in the presence of recombination 
The processes of recombination and natural selection can impact genetic 
variation in similar ways and create artifacts for interpreting results.  In particular, 
hotspots of recombination can inflate dN/dS ratios to produce a false positive result of 
adaptive evolution (181, 182). To control for this potential artifact, we implemented the 
program omegaMap on the 45 vacA alleles assembled for the MKT to evaluate rates of 
recombination and dN/dS ratios across the p55-encoding region of the vacA gene. The 
distribution of recombination and selection confirms that different regions of the protein 
experience different evolutionary pressures. In particular, the average population rate of 
recombination (rho) per codon within the p55 domain is 0.48 ± 0.01 (mean ± standard 
error), which is significantly lower than the average rho for all codons outside of the p55 
domain, 0.84 ± 0.01 (Mann-Whitney U test, p < 0.0001).  Lower recombination rates in 
the p55 domain are consistent with our finding that p55 harbors the amino acid 
differences that structure the divergence of the full-length VacA sequences into three 
distinct groups. Consistent with the results of the sliding window, McDonald-Kreitman, 
and PAML analyses, the omegaMap analysis also identifies positively-selected sites with 
a dN/dS ratio > 1 and a posterior probability > 0.95. Residue D667 was found to be 
under strong, positive selection (dN/dS = 5.3, posterior probability = 1.0) and residue 
M663 was marginally nonsignificant (dN/dS = 1.6, posterior probability = 0.78).  Notably, 
these positively-selected sites were recapitulated among the sites identified in the PAML 
analysis (Figure 30).  These surface-exposed residues are adjacent to each other in the 
VacA p55 domain crystal structure (Figure 30C, magenta and red).  Finally, we analyzed 
sites undergoing positive selection within each group (N = 15 alleles each) and found 
three additional residues (E799, N800, G801) in sequences from Group 3 (type m2 
VacA) that are positively selected (dN/dS = 2.4, posterior probability = 0.95, 0.96, 0.95, 
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respectively) (Figure 30C, blue) and one adjacent residue, G802, that was marginally 
nonsignificant (dN/dS = 1.5, posterior probability = 0.74).   
The β-helical structure of VacA presents a unique opportunity for studying the 
pressures of positive and negative selection in a structural context, since the residues 
are in an alternating pattern of facing inside and outside the β-barrel.  All residues 
identified to be under positive selection are surface exposed.  Initially, since the selection 
was in the p55 region, we speculated that the surface-exposed amino acids were 
important for receptor binding.  Since we are able to obtain purified p33 (Chapter III), 
and it is functional when mixed with p55, we had a recombinant system to test the effect 
of mutations.  Two adjacent residues (M663 and D667) identified to be under positive 
selection, were chosen for site-directed mutagenesis, resulting in two double mutants; 
M663A/D667A or M663A/D667K.  The mutants were tested in three cell culture assays 
(methods described in Chapter III, cell culture assays):  vacuolation, IL-2 secretion and 
cell apoptosis (Figure 31A-C).  In each assay, the mutant p55 mixed with p33 behaved 
similarly to wildtype.   
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Figure 31.  Effects of wildtype p33 and wildtype and mutant p55 VacA proteins on 
HeLa, AZ-521 and Jurkat cells.  p33 was refolded as described in Methods. Wildtype 
and mutant purified p55 and wildtype p33 (each 1 mg/ml) were mixed together in a 1:1 
mass ratio, which ensured an excess of p33 on a molar basis. The p88 VacA protein 
purified from H. pylori culture supernatant was acid-activated prior to contact with cells 
(106, 110), whereas the p33 or p55 preparations were not acid-activated.  M663A 
/D667A p55 (AA) mutant, and M663A/D667K p55 (AK) mutant were tested in the activity 
assays.  (A) HeLa cells were incubated with the indicated purified VacA proteins at a 
final concentration of 10 µg/ml (or 5 µg/ml of each protein in the case of p33/p55 
mixture).  Cell vacuolation was quantified by neutral red uptake assay (OD 540 nm). (B) 
AZ-521 cells were incubated with a p33/p55 mixture at the indicated final concentrations 
(20 µg/ml corresponds to 10 µg/ml p33 and 10 µg/ml p55). Cell viability was quantified 
by CellTiter-Glo.  (C) Jurkat cells were incubated with the indicated purified VacA 
proteins at a concentration of 6 µg/ml (or 3 µg/ml of each protein in the case of the 
p33/p55 mixture), and IL-2 secretion was measured as described in Materials and 
Methods.   Results represent mean ± standard deviation, based on analysis of triplicate 
samples.   
 94  
 
We hypothesized that these residues may be important for secretion, since they 
were not important in the in vitro cell culture assays.  The M663A/D667A mutant was 
introduced, via homologous recombination, into VacA from H. pylori.  There was no 
effect on the secretion of the mutant VacA compared to wildtype (Figure 32).  
Since the functional tests were negative, we hypothesize that this selection in the 
p55 region may be important for antibody evasion or maybe a consequence of immune 
selective pressure.  Previous studies have shown that anti-VacA antibody responses are 
primarily against the p55 domain rather than the p33 domain, and these antibodies can 
neutralize VacA activity.   Therefore, positive selection within the p55 domain may have 
been driven by evasion of host immune responses.  H. pylori is known to live and 
colonize the gastric mucosa layer and can persist for a long period of time.  Immune 
evasion may be an important feature for the successful colonization and persistence of 
H. pylori.  
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Figure 32.  Immunoblot showing secretion of VacA p88 and M663A/D667A VacA 
p88 from H. pylori.  Lanes 1 and 2 are bacterial pellet and supernatant, respectively, 
from wildtype VacA.  Lanes 3 and 4 are bacterial pellet and supernatant from M663A 
/D667A mutant VacA p88.    
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Rooted phylogenetic analyses of VacA and housekeeping genes  
The three-group phylogenetic structure of VacA (Figure 23) has been shaped by 
positive selection associated with distinct geographic distributions.  H. pylori 
housekeeping genes also exhibit geographic diversity (158, 159), but presumably there 
has been very little positive selection upon housekeeping genes because the genes 
used for these analyses are conserved and typically under purifying selection.  
Therefore, we hypothesized that there would be marked differences in the evolutionary 
history and phylogeography of vacA compared to housekeeping genes.  
To generate a rooted tree of housekeeping gene sequences, we selected a total 
of 61 sequences from representative H. pylori strains that previously had been classified 
into nine geographically distinct populations and subpopulations based on MLST 
analysis (158), as well as strains that were used in the analysis of VacA.   We used the 
corresponding housekeeping genes from the close relative H. acinonychis to root the 
tree (176). The Bayesian root of this tree is confidently positioned in taxa classified by 
MLST analysis as HpAfrica2, a population currently found almost exclusively in South 
Africa (158, 159) (Figure 33), and the next most closely related taxa are also of African 
origin (classified as HpSouth Africa or HpWest Africa subpopulations).  To confirm the 
rooting position in African populations, we excluded the HpAfrica2 taxa, repeated the 
analysis, and again observed the rooting position in the set of South African taxa.  
Rooting of the MLST tree within African taxa is consistent with previous reports of an 
ancient African origin for H. pylori in humans (158, 159).   The phylogenetic analysis 
suggests a spread of H. pylori from Africa to Europe, and then from Europe to East Asia 
and the American Hemisphere.  Previous analyses of genetic diversity in H. pylori 
indicated that the global spread of H. pylori mirrored that of its human hosts (159).   The 
current analysis confirms the hypothesis that H. pylori, indeed, has African origins.  If we 
crudely extrapolate human migration patterns from the H. pylori phylogeny as has been 
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done in other population genetic studies, our analysis suggests that migration from the 
Eastern coast of Africa led to human colonization of Europe before Asia. The basic 
reason is that the earliest branching taxa from the African H. pylori lineages are 
classified as HpEuropean, while the HpAsia2 populations (currently found in Northern 
India and Southeast Asia) branch off from the ancestors of the European taxa.   
Deducing the routes of human migration is complex, and will require synthesizing other 
evidence beyond the H. pylori data. 
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Figure 33.  Rooted (A) MrBayes and (B) PhyloBayes phylogenetic trees of 
concatenated housekeeping gene. Nucleotide sequences of 7 housekeeping genes 
(atpA, efp, mutY, ppa, trpC, ureI, yphC) from 61 strains of H. pylori and 1 outgroup, H. 
acinonychis, were analyzed.  Sequences representing nine previously described 
populations or subpopulations of H. pylori (158, 159) are color-coded on the tree:  
hspMaori, hspEAsia, hpAsia2, hspAmerind, hpEurope, hspWAfrica, hpNEAfrica, 
hspSAfrica, and hpAfrica2.  The numbers represent Bayesian posterior probability 
values for each node.  Asterisks indicate strains that were also analyzed in Figure 34.  
Strains are labeled with “id numbers” that are used in an H. pylori multilocus sequence 
typing database (http://pubmlst.org/helicobacter), and the population assignments of 
strains based on MLST analysis (158, 159) are indicated.    
A 
B 
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We next generated a rooted tree of full-length VacA sequences (Figure 34) using 
the vacA pseudogene in H. acinonychis as an outgroup (176).  We aligned the VacA 
amino acid sequence of H. acinonychis with 24 ingroup taxa, corresponding to H. pylori 
VacA sequences that were representative of VacA Groups 1-3 (Figure 23).  To increase 
representation of African VacA sequences in this tree, we determined the vacA 
sequences of three additional H. pylori strains of African origin (including two strains 
classified as HpAfrica2 based on MLST analysis).  The resulting 971-amino-acid 
sequence alignment yields Bayesian and PhyloBayesian phylogenies (Figure 34) 
showing that the VacA root is confidently positioned in the CHN3295 and CHN5147 
taxa.  These strains, isolated in Shanghai, China, (164) have m2 sequence 
characteristics and belong to the Group 3 subgroup II of the full-length VacA tree (Figure 
23).   The next earliest branching lineage includes the Group 3 subgroup I strains, which 
also have m2 sequence characteristics and were isolated in many different geographic 
locations.  Three observations suggest the VacA rooting position is accurate:  (i) First, 
the rooting position in m2 Asian strains issupported with two different inference methods, 
MrBayes and PhyloBayes; (ii) three different models of evolution (CAT, WAG, JTT) and 
removal or addition of other m2 Asian strains and hypervariable regions does not alter 
the rooting position; in particular, the probabilistic inference model, CAT, accounts for 
across-site heterogeneities and can handle model misspecifications associated with long 
branch attraction (171) artifacts (177); and (iii) the maximum amino acid identity of the 
outgroup with Asian m2 (65.4%) or non-Asian m2 sequences (64.0%) is greater than 
that of the outgroup with Asian m1 (57.4%) or non-Asian m1 sequences (51.1%).   Thus, 
a comparison of the rooted trees confirms that there are substantial differences in the 
phylogenetic structure of VacA compared to housekeeping gene sequences.  
Furthermore, to statistically test the topological incongruence between the VacA and 
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MLST phylogenies, we compared the ML phylogenies of 14 taxa common to both 
datasets using the Shimodaira-Hasegawa (SH) test (Figure 35).  The MLST and VacA 
datasets show unambiguous significant differences (p < 0.0001 for both, Figure 35A and 
B, respectively), indicating the VacA toxin gene has not coevolved with the core genome 
of H. pylori.   
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Figure 34.  Rooted (A) MrBayes and (B) PhyloBayes phylogenetic trees of VacA 
sequences.  Twenty-four representative VacA sequences from Groups 1-3 (Figure 23) 
and 1 outgroup, deduced from the reconstructed H. acinonychis vacA pseudogene were 
analyzed.  Four major groups are indicated: m2 Asian group (corresponding to the 
Group 3 subgroup, brown, in Figure 23), m2 Western group (Figure 23 Group 3, red), 
m1 Asian group (Figures 23 Group 2, blue), and m1 Western group (Figure 23 Group 1, 
green).  The numbers represent posterior probability values for each node. Asterisks 
indicate strains that were also analyzed in Figure 33.     
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Figure 35.  Topological differences in VacA and MLST phylogenetic trees using 
the Shimodaira-Hasegawa (SH) test.  The Neighbor-joining phylogenetic trees from 
the Shimodaira-Hasegawa test shows the 14 taxa used in the analyses and evolutionary 
relationships for (A) MLST and (B) VacA.  The taxa used were identical for both the 
MLST and VacA trees.   
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CagA phylogeography   
In H. pylori strains 26695 and J99, vacA and cagA  (encoding the secreted 
effector protein CagA) are located ~350 kb apart in the genomes.  VacA can 
downregulate CagA’s effects on epithelial cells and CagA can protect cells against the 
apoptotic effects of VacA (166, 168).  Furthermore, VacA can counteract the ability of 
CagA to activate NFAT in gastric epithelial cells (167).  We thus hypothesize that these 
two genes share an evolutionary history characterized by co- or counter-adaptations in 
response to a common selective pressure.  We identified 46 H. pylori strains for which 
both VacA and CagA sequences were available.  Phylogenetic analysis of the full-length 
CagA sequences revealed three groups (Figure 36), similar to the phylogeny of VacA 
(Figure 23).  In the CagA analysis, Group 1 consists of seven sequences that are 
predominantly from strains of Western origin (Figure 36). The corresponding VacA 
sequences from these strains are characterized as m1 Western and are found in Group 
1 in the full-length VacA tree (Figure 23).    CagA Group 2 consists of 25 exclusively 
Asian sequences; the corresponding VacA sequences are characterized as m1 Asian 
and are found in Group 2 in the full-length VacA tree.  Finally, CagA Group 3 consists of 
11 exclusively Asian sequences; the corresponding VacA sequences are characterized 
as m2 and are found in Group 3 in the full-length VacA tree. Thus, the CagA 
phylogenetic tree strikingly resembles the full-length VacA tree and suggests that CagA 
and VacA are coevolving due to a similar selective pressure. A McDonald-Kreitman test 
indicates that positive selection has significantly shaped CagA divergence of Group 2 
from both Group 3 (p < 0.005, NI = 0.58) and Group 1 (p < 0.018, NI = 0.66). These 
findings indicate that both VacA and CagA are under positive selection and suggest for 
the first time that these virulence determinants coevolved in concert.  The resulting 
diversity in VacA and CagA sequences potentially modulates the activities of these 
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proteins and could be a factor that influences the risk for development of peptic 
ulceration or gastric cancer in H. pylori-infected persons.   
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Figure 36.  Analysis of CagA phylogeography.  Neighbor-joining phylogenetic tree of 
46 CagA amino acid sequences.  Three major groups are evident: Group 1 consists 
predominantly of sequences from strains of Western origin, Group 2 consists of Asian 
sequences, and Group 3 consists of Asian sequences. The chart shows the number of 
strains analyzed and characteristics of VacA sequences in each group of the tree.  CagA 
sequences shown in Groups 1 and 2 correspond to H. pylori strains containing type m1 
VacA (Groups 1 and 2 of Figure 23), whereas CagA sequences shown in Group 3 
correspond to strains containing type m2 VacA (Group 3 of Figure 23).  The 
nomenclature for the primary CagA groups (Groups 1, 2, and 3) is consistent with the 
nomenclature of groups in the full-length VacA tree (Figure 23). 
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In summary, our key findings indicate for the first time that (i) VacA sequences 
are divided into three distinct groups on the basis of amino acid sequences, and different 
VacA domains exhibit different evolutionary histories reflecting diverse molecular 
evolutionary pressures.  (ii) VacA has undergone strong divergence and positive 
selection in the p55 domain (iii) The phylogeographic features of VacA and CagA are 
surprisingly similar, yet markedly different from the phylogeographic features of 
housekeeping genes, which reflect a global spread of H. pylori out of Africa.  This result 
suggests that there is a related selective pressure on both VacA and CagA.   Since there 
is substantial physical distance between vacA loci and cag genes within the bacterial 
genome, the selection of a vacA/cagA coadapted genotype may be due to a form of 
pseudolinkage of functionally-interacting genes that perhaps balances proinflammatory 
and anti-inflammatory characteristics of strains to facilitate long-term colonization of the 
human gastric mucosa.  The present work therefore provides the first evidence for 
selection-driven changes in H. pylori virulence determinants associated with peptic 
ulceration and gastric cancer. 
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CHAPTER V 
 
 
CONCLUSIONS 
 
 
 
Summary 
 
 
 H. pylori is the causative agent of most cases of peptic ulcer disease and a major 
risk factor for the development of gastric cancer.  Experimental and epidemiological 
studies suggest that VacA is an important virulence factor in H. pylori pathogenesis and 
linked to severe gastric tissue damage (183).  In vitro, VacA induces various cytotoxic 
effects, while in vivo, the relevance of these phenomena for H. pylori gastric infection 
and alteration is mostly undefined.  Structural and functional studies of VacA should 
provide information needed to address this knowledge gap.  
Prior to undertaking this thesis project, two putative VacA domains had been 
described in the literature.  The mature secreted 88 kDa VacA can undergo proteolysis 
into 33- and 55- kDa fragments termed p33 and p55, respectively. This thesis has 
provided insight into the importance of these domains for VacA assembly into oligomers, 
the structural and functional correlates of VacA sequence diversity as well as how 
molecular evolution has shaped VacA.   
Chapter II of this thesis describes the use of x-ray crystallography to determine 
an atomic structure of the p55 receptor-binding domain.  The structure is an elongated β-
helix molecule that is typical of autotransporter proteins.  VacA sequence polymorphisms 
were examined in the context of the structure in an effort to understand how genetic 
differences between m1 and m2 vacA alleles relate to structural and functional 
differences in the proteins they encode.   In addition, docking of the high-resolution p55 
domain in the dodecamer VacA p88 EM map and the identification of a highly conserved 
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N-terminus of p55, as shown by analysis of VacA sequence polymorphisms associated 
with the m1 and m2 forms of VacA, provide strong evidence that the p33 domain 
extends the β-helix and interacts with the neighboring p55 domain.  This interaction 
plays an important role in VacA oligomerization.      
 Chapter III describes the expression and refolding of p33.   This chapter also 
describes how purified p33, when added in trans to purified p55, reconstitutes a 
functional protein.  Furthermore, it was demonstrated that both domains were required 
for VacA binding and internalization into host cells.   Also, purified p33 and p55 
assemble into oligomeric structures in the presence of amphipathic molecules.  In the 
presence of detergent, single-layered forms are the predominant species.  This is 
interesting because we hypothesize that single-layered forms represent the relevant 
physiological structures required for pore formation. VacA p88 from H. pylori must first 
be acid-activated in order to cause an effect on cells, whereas purified p33 and p55 do 
not require this pre-treatment for activity.  Finally, the recombinant expression of active 
p33 is a major step forward in our efforts to further understand VacA structure-function 
relationships, since this fragment can be produced in the large amounts required for 
future crystallography experiments.   
 In Chapter IV, we analyzed the molecular evolutionary forces acting on VacA.  
vacA genes from a large set of H. pylori strains were analyzed in a population genetic 
context.  VacA sequences cluster into three groups with distinct geographic distributions 
and adaptive evolution in VacA is restricted to the p55 domain.  Since the crystal 
structure was determined in Chapter II, we could map positively selected sites to the 
structure.  The specific amino acids that were identified to be under positive selection 
map to surface exposed residues.  It is possible that the correspondence of positively 
selected VacA sites to surface-exposed residues of p55 is important for immune evasion 
or may have arisen in response to immune selective pressures.  In this chapter, we 
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confirmed, by a rooted phylogenetic analysis of H. pylori housekeeping genes, the 
theory that H. pylori originated in Africa and spread throughout the world along with the 
major human migration events.   Rooted phylogenetic analysis of the origins of VacA 
reveals that the ancestry of VacA is strikingly different from the African origins that typify 
the core genome.  Finally, the virulence determinant CagA is also under positive 
selection and has a three-group phylogeny that is strikingly similar to that of VacA, 
suggesting that the natural selection of VacA and CagA have been coupled. 
 
Future Directions 
  
We are interested in further dissecting the role of VacA in H. pylori colonization, 
persistence, and pathogenesis.  Specifically, we are interested in understanding the 
relevant receptors for inflammatory and immunomodulatory responses, the molecular 
details of how VacA binds those receptors, the cellular events required for 
oligomerization and pore-formation, and the VacA pore structure.   Moreover, we would 
like to understand if vacuolation is relevant to the function of VacA or a ‘by-product’.  
Additionally, there are numerous papers that suggest VacA inserts into the mitochondria 
(90, 184-188), but the trafficking of VacA is not clear.  Finally, an animal model that more 
accurately reflects the complex balance between inflammation and persistence is 
needed to further address the effect of VacA in vivo.  We plan to address VacA receptor 
binding, oligomerization, and pore formation in the following future experiments.  These 
future studies are expected to lead to important new insights into the role that VacA 
plays in bacterial colonization of the host and evasion of host immune defenses.   
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Identify the region of VacA important for binding carbohydrate  
A number of VacA glycoprotein receptors have been reported in the literature.  
We were unable to detect specific, saturable binding to gastric epithelial cells using flow 
cytometry and radiolabeling of the ligand (Appendix).  We were particularly interested in 
pursuing structural studies on the VacA αLβ2 integrin complex but were unable to detect 
an interaction using biochemical methods (data not shown).  Since we used a 
CHO3.2.8.1 cell line to express the integrin ectodomain, we hypothesized that the failure 
to see binding was a result of improper integrin glycosylation.  To better understand the 
glycan binding profile of VacA, we sent VacA p55 and the full-length VacA p88 to a 
glycan array-screening core, the Consortium for Functional Glycomics.  The strongest 
interactions, binding to sialylated 2-3 structures, were observed for p88, but not p55 
(Figure 37).  Additionally, when p88 was acid activated, binding to 2-3 sialyated 
structures was still observed (Figure 37B).  Only one sugar (GlcAb1-3GlcNAcb-Sp8) was 
found to bind the p55 region of VacA (Figure 37C).   This suggests that the binding to 
carbohydrates stems from the p33 region of VacA and oligomerization is not required 
(Figure 37).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 111  
                
 
                
                
 
Figure 37.  VacA p88 interaction with the glycan array.  (A) VacA p88 binding at pH 
8.0  (B) VacA p88 binding at pH 3.0 (C) VacA p55 binding at pH 7.0 
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One goal for future studies is to verify and visualize this interaction to 2-3 sialic 
acid, identify the region of VacA important for this interaction, and generate and test 
VacA mutants in cell-based assays.  We will purify oligomeric VacA p88, add 2-3 
sialylated sugar bound to streptavidin and detect binding by adding a nano-gold 
molecule linked to biotin.   We can visualize the gold molecule by EM and identify the 
region of VacA p88 important for this interaction.   We will generate mutations within this 
region and test these mutants for binding, pore formation, and signaling in gastric 
epithelial cells.   
 
Determine a high-resolution crystal structure of VacA p88 or VacA p33/p55 
The structure of VacA p55 (Chapter II) allowed us to define the structural 
features of VacA that may contribute to its cell-binding and oligomerization properties as 
well as the structural correlates of VacA sequence variation.  However, the structural 
picture of VacA is not complete, because an atomic view of the p33 domain does not 
exist.  We hypothesize that a high-resolution crystal structure of p33 will provide further 
insight into how VacA assembles into higher-ordered oligomers and allow us to begin to 
dissect how VacA forms pores.  Additionally, we will be able to test our hypothesis that 
p33 adopts and extends the β-helix fold observed in p55. 
VacA p88 forms a heterogeneous mixture of water-soluble oligomeric structures 
and is therefore not ideal for crystallization studies.  With the advent of the p33 
expression system described in Chapter III, we are able to obtain large quantities of 
refolded p33.  We have screened over 480 buffer conditions in attempts to crystallize 
p33 but the protein precipitates in the majority of the conditions and high levels of 
guanidine and arginine are required in the buffer.  We mixed p33 and p55 together in an 
attempt to reduce the amounts of guanidine and arginine.  However, even though it 
formed monomeric p88 (Chapter III), the guanidine and arginine could not be reduced.  
 113  
We further demonstrated that p33/p55, in the presence of detergent and absence of 
guanidine, formed oligomers.  We hypothesized that these oligomers were all single-
layered and may form a more homogeneous sample of oligomers.  However, even 
though the majority were single-layered (Chapter III, Figure 21), they were still 
composed of hexamers and heptamers and double-layered forms were still present.   
To circumvent these obstacles, we have constructed an oligomerization deficient 
mutant.  It has been shown that residues 346-347, which are located in the p55 domain, 
are required for oligomerization (121).  A deletion mutant was made in VacA p88 from H. 
pylori using a homologous recombination system.  The expression level of delta 346-347 
VacA p88 was decreased significantly and there is currently no purification system 
available for monomeric p88.  However, we can take advantage of our recombinant 
expression system for p33 and p55 proteins.  Amino acids 346-347 were deleted in the 
recombinant p55 and then mixed with wildtype, recombinant p33.  This forms monomeric 
p88 and does not oligomerize.   I setup crystal trays with this protein at 6 mg/ml, and 
35% of the wells remained soluble.  This is a promising result, and future studies will 
include screening more buffer conditions, using a higher protein concentration, and 
setting up crystal trays at different temperatures.   
Amino acids 49-57 in the p33 domain are also required for oligomerization.  
These amino acids were deleted in the recombinant p33 and mixed with wildtype, 
recombinant p55. Again, this forms monomeric p88 as judged by gel filtration 
chromatography.  The oligomerization deficient mutants provide an attractive system for 
future crystallography studies.   Additionally, we can use the oligomerization deficient 
mutants to further dissect channel-dependent and independent activities and signaling 
functionality on cells.  We know these mutants are not functional in the vacuolation 
assay since oligomerization is important for vacuolation.  We do not know, however, if an 
oligomerization deficient mutant will be functional in the Git1 or p38-signaling assay.  
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VacA p55 can activate Git1; however, p55 forms dimers, which may be sufficient for 
activation (87).  VacA oligomers may crosslink the receptors, resulting in the induction of 
signaling or internalization pathways.    
An alternate path to obtain the crystal structure of p88 is to recombinantly 
express p88.  We have tried to express p88 recombinantly using E.coli; however, there 
is low expression and there is breakdown of p88 into p33 and p55.  Bacillus megaterium 
has been gaining more popularity as an efficient alternative to E.coli.  B. megaterium as 
an expression host relies on the xylose operon as a regulatory element and has the 
advantage that none of the alkaline proteases are present. This enables expression of 
foreign proteins without degradation.  Moreover, no endotoxins are found in the cell wall 
and protein yields are exceptionally good.  I have recently cloned p88 into the B. 
megaterium vector.  If the protein expresses, the first step will be to see if the protein 
oligomerizes by gel filtration and EM.  If so, we can easily construct an oligomerization 
deficient mutant in this recombinant system, and use this protein for crystallography 
studies.  Finally, another alternate approach would be to express oligomerization-
deficient p88 to inclusion bodies and refold the protein.  This approach was used for the 
expression and purification of p33 in Chapter III. 
 
Determine the structure of VacA in a pore state 
Following receptor binding and oligomerization, VacA is thought to insert into the 
membrane and is then internalized which leads to the formation of vacuoles.  Expression 
of VacA in transfected cells results in cell vacuolation, which suggests that VacA has an 
intracellular site of action.  This vacuolating activity is hypothesized to be the 
consequence of anion-selective channel formation in late endosomal compartments (61, 
78, 79, 81, 189) 
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A 2D crystal structure of VacA on lipid bilayers would reveal the structural 
features important for pore formation.  Atomic force microscopy has shown that below 
pH 5, VacA associates with anionic lipid bilayers to form hexameric membrane-
associated complexes (61) and forms pores across planar lipid bilayers.   
Czajkowsky et al have produced VacA 2D crystals on anionic phospholipid 
bilayers.  The VacA crystals reveal a hexagonal pattern of rings and possess the same 
general characteristics as observed both with the water-soluble dodecamer and with the 
isolated membrane-associated oligomers observed at pH < 5.   Height measurements 
suggest that the oligomer is single-layered.  Furthermore, pore formation presumably 
requires that VacA must insert and span the entire bilayer.  The VacA hexamer is only 
about 4.8 nm and protrudes only 2.9 nm from the bilayer, suggesting that a large 
conformational change is required during insertion.   We plan to recreate these 2D 
crystals by using the methods described previously (61).  Electron crystallography will 
allow for the reconstruction of a three-dimensional model of the VacA pore state.   
Currently, the highest resolution image of a VacA oligomer is a 19 A EM map of 
the VacA dodecamer (107).  In collaboration with the Ohi lab, we will use cryo-electron 
microscopy to determine a high-resolution structure of a VacA oligomer.  Progress has 
been hampered because VacA from H. pylori forms a heterogeneous mixture of 
oligomers.  To help improve homogeneity, we can reconstitute the VacA oligomers by 
mixing the purified domains (p33 and p55) with detergent (Chapter III).  By using this 
process, we obtain mostly single-layered species (Chapter III, Figure 21), which will 
improve the number of EM particles and improve particle collection.  By comparing this 
structure to the 3D structure obtained by 2D Electron crystallography, we can begin to 
elucidate how this toxin inserts into the membrane and forms pores.   
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Concluding Remarks 
The future directions I have outlined rely heavily on the tools of structural biology, 
methods I have come to appreciate over the course of my graduate work.  The pictures 
these methods provide should offer the molecular detail needed to dissect the 
physiological roles of VacA in H. pylori function.   
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APPENDIX 
 
FORAYS INTO RECEPTOR BINDING 
 
Introduction 
 
The molecular basis for the role of VacA in pathogenesis has been complicated 
by the fact that it binds multiple receptors and can trigger a variety of cellular effects.  
Several lines of evidence indicate that the initial interaction of VacA with its target cell is 
mediated by interaction with receptor(s), which trigger receptor-mediated signaling 
events or the formation of membrane channels (76, 91, 190-192).  VacA may contain 
multiple receptor-binding sites, each of which is optimized for binding to a different 
receptor (128).  Moreover, there appear to be significant functional differences 
depending on the type of vacA allele present, m1 or m2.  Type m1 and m2 forms of 
VacA can differ in their cell-type specificity, implying the roles of discrete receptors 
and/or sequence polymorphisms in the receptors from different human populations.  
Furthermore, m1 strains of H. pylori are associated at higher frequency with gastric 
cancer (87-89).   The underlying process by which VacA interacts with multiple 
components of the plasma membrane is poorly understood.   
Identification of the VacA receptor binding sites can be accomplished with site-
directed mutagenesis and an assay in which the receptor-binding affinities of different 
VacA mutants can be compared.  Past experiments, using H. pylori purified VacA, have 
suggested that VacA binds either non-specifically or to abundant, low-affinity receptors 
on HeLa cells (191).  With the advent of a GST-fusion and flow cytometry assay, Wang 
and colleagues have shown specificity and saturability in binding and that the GST-VacA 
fusion has a binding activity similar to that of the native toxin (119, 128).  The use of the 
 118  
N-terminal GST-fusion protein inhibits VacA oligomerization.  Kinetic and Scatchard 
analysis revealed a specific high-affinity receptor interaction with a measured affinity of 
KD ~ 5 nm (119, 128).  This value, however, may need to be reconsidered because of 
the capacity of GST to dimerize.   
A specific, saturable interaction has never been demonstrated with the p55 
domain alone, even though several studies have implicated the importance of this 
domain in binding to host cells (68, 117-119, 128).  We wanted to develop a sensitive 
assay to detect subtle differences in binding between m1 and m2 forms of purified VacA  
p55 domain in an effort to identify specific amino acids important for their interactions 
with host cells. We developed a flow cytometry binding assay where we incubated 
trypsinized cells (105) with His-p55 VacA.  Cells were incubated with anti-His antibody, 
and incubated with goat anti-rabbit phycoerythrin.  Flow cytometric analyses were 
carried out at the Vanderbilt Flow Cytometry Core Laboratory.  For competition 
experiments, cells were incubated with a 100-fold molar excess of the cleaved (His 
removed) wildtype VacA p55.  With this assay, we were able to show specific binding, 
however, the binding was not saturable and we could not calculate a binding affinity 
(Figure 38).  In an effort to gain sensitivity, we developed a radioligand binding assay, 
where we added 125I -p55 (hot) to AGS cells in the absence or presence of 100 fold 
excess of unlabeled p55 (cold) (Figure 39).  Again, binding was not saturated.  A 
possible explanation is that VacA binds to multiple cell surface components on gastric 
epithelial cells due to its “sticky” nature.   Finally, evidence for a specific receptor is 
lacking and needs to be reevaluated.   
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Figure 38.  Analysis of VacA p55 binding to Human Adenocarcinoma Gastric 
Epithelial Cells (AGS) by flow cytometry.  AGS cells were incubated in medium, 2% 
fetal bovine serum with His-p55 alone or plus a 100-fold molar excess of p55 (His-tag 
removed) at various concentrations. Specific binding is the difference between total 
binding and nonspecific binding.  The lower panel represents a log scale of specific 
binding.   
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Figure 39.  Analysis of VacA p55 binding to Human Adenocarcinoma Gastric 
Epithelial Cells (AGS) by radioiodination.  AGS cells were incubated in medium, 2% 
fetal bovine serum with 125I  ‘hot’ His-p55 alone or plus a 100-fold molar excess of cold 
His-p55 at various concentrations. Specific binding is the difference between total 
binding and nonspecific binding.  The lower panel represents a log scale of specific 
binding.    
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